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 EFFECT OF AN ACUTE BOUT OF AEROBIC EXERCISE ON 
DEHYDROEPIANDROSTERONE SULFATE (DHEAS) IN CLINICALLY DIAGONSED 
BIPOLAR SUBJECTS 
 Anne E. Hays, MS 
University of Pittsburgh, 2007
Dehydroepiandrosterone Sulfate (DHEAS) is thought to offset hypercortisolemia, which is found 
in individuals with bipolar disorder.  While the cause of bipolar disorder remains unknown, 
previous studies have linked elevated cortisol levels with various mental health illnesses, 
including bipolar disorder.  Previous studies suggest that exercise increases DHEAS levels in 
healthy subjects, however no studies have tested clinically diagnosed bipolar patients.  It is 
hypothesized that the interaction between DHEAS and cortisol may be a contributing factor to 
the improvements in mood seen with exercise (McEwen 2002).  
 
PURPOSE:  To determine the effect of an acute bout of aerobic exercise on DHEAS 
levels and perceptions of well-being in clinically diagnosed bipolar disorder patients.   
 
METHODS: Clinically diagnosed male (n=13) and female (n=13) bipolar patients (mean 
age 42.4 + 11.4 years) participated in this study.  Ten ml of blood were drawn prior to the 
exercise session.  Subjects walked on a treadmill for 20 min. at individualized intensities 
corresponding to 70% of age predicted maximum heart rate (APMHR).  The exercise session 
finished with a 5 min. cool down.  Within five min. post- completion of the cool down, a second 
blood draw, identical to the first, occured.  Blood samples were spun and serum frozen until all 
samples could be collected and analyzed.  A 7-point Likert questionnaire was administered pre 
and post exercise to assess perceptions of well-being.   
 
RESULTS: A two way ANOVA revealed a significant increase in DHEAS (p=0.01) 
after the acute bout of aerobic exercise.  A dependant T-test also revealed a significant 
improvement in perception of global well-being following exercise (p<0.05).  A non-significant 
(p=0.38) correlation of r=0.18 was found between DHEAS and perceptions of well-being.   
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 CONCLUSION: Treadmill exercise performed at of 70% of APMHR for 20 min. 
significantly increased DHEAS in clinically diagnosed bipolar subjects.  Significant post 
exercise perceptions of well being improved.  No relationship between well-being and DHEAS 
was revealed.  Exercise appears to be responsible for an increase in DHEAS in bipolar patients; 
however, it appears that this increase may not be solely responsible for improvements in well-
being.  
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1.0  INTRODUCTION  
Bipolar disorder, also known as manic-depressive illness, is a mood disorder that causes unusual 
changes in one’s energy, mood, and ability to function.  Many healthy individuals go through 
normal mood swings; however the symptoms of bipolar disorder are different.  Symptoms are 
more severe and can result in poor school or job performance, damaged relationships and even 
suicide.   
More than 2 million American adults (Narrow, 1998), or about 1 percent of the 
population over the age of 18 have bipolar disorder.  Bipolar disorder typically develops in late 
adolescence or early adulthood.  Similar to diabetes or heart disease, bipolar disorder is a long-
term illness that must be carefully managed throughout a person’s life.   
In 1990 the cost associated with this disease was estimated to be 44 billion dollars (Wyatt 
et al., 1995).  Seventeen percent of those costs were from direct care including inpatient 
treatment, medication, and shelter.  The remaining 83% was attributed to worker absenteeism, 
diminished productivity, institutional costs and assisted living expenses.  It is estimated that the 
financial impact of a single occurrence of this disease is over $11,000 per patient, while unstable 
and reoccurring bipolar disorder can cost upward of $625,000 across the lifetime of a single 
patient (Begley, 2001). 
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Dramatic mood swings ranging from overly “high” to irritable to sad and hopeless 
describe this disorder.  Severe changes in energy and behavior typically accompany these 
changes in mood.  A typical manic episode could include any of the following symptoms:  
increased energy, activity and restlessness, excessively high euphoric mood, irritability, racing 
thoughts and quick speech, distractibility, insomnia, unrealistic beliefs in one’s ability or power, 
poor judgment, spending sprees, increased sex drive, abuse of drugs, provocative or aggressive 
behavior, and denial that anything is wrong.  This mania is then followed by an episode of 
depression, which has the same symptomology as unipolar depression.  These symptoms include, 
but are not limited to:  feelings of sadness, anxiousness, empty mood, hopelessness, pessimism, 
feelings of guilt, worthlessness, helplessness, loss of interest in activities once enjoyed, 
decreased energy, difficulty concentrating, remembering, making a decision, restlessness, 
sleeping too much, change in appetite or unintended weight loss or gain, chronic pain or other 
persistent bodily symptom that is not caused by physical illness, and thoughts of suicide or death.   
Studies are currently being done to clarify the possible causes of bipolar disorder.  Most 
scientists now agree that there is no single cause of the disorder; rather many factors acting 
together cause the disease.  Bipolar disorder tends to run in families. Therefore recent research 
has focused on uncovering genes that may be associated with its etiology.     
Bipolar disorder is a recurrent illness, so long-term preventative treatment is strongly 
recommended and almost always indicated.  Bipolar disorder patients are at risk of switching 
into mania or hypomania or of developing rapid, or ultra rapid cycling during treatment with 
antidepressant medication (Thase 2000).  Rapid cycling can be defined as having four or more 
distinct periods of depression, hypomania, mixed states, or mania in one calendar year.  In ultra 
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rapid cycling, these episodes may last no more than 24 hours and may give the individual little 
break from abnormal moods between mood swings.   “Mood-stabilizing” medications are 
generally required, alone or in combination with antidepressants in an attempt to prevent patients 
from this cycling.  Researchers continue to evaluate potential alternative therapies, as 
medications have known adverse side effects including: weight gain, nausea, tremor, reduced 
sexual drive, anxiety, hair loss, movement problems, and dry mouth, just to name a few.  
Lithium, which is a commonly used mood stabilizer, may cause low thyroid levels in some 
people resulting in the need for further medication.   
One possible alternative form of therapy is physical activity or exercise.  Exercise has 
many proven physical and mental health benefits.  Physically fit individuals typically are more 
successful in everyday activities than sedentary individuals.  In addition, they are better able to 
withstand disease, infection and declines in functionality.  These health-fitness adaptations 
typically accrue when exercise is completed with appropriate intensity for 30 minutes or more on 
most days of the week.  However, due to the complexity of various disease states associated with 
a sedentary lifestyle, there may be no single minimal dose of physical activity that is protective 
for all clinical conditions.   
There is a growing body of literature dealing with the effects of exercise on mental health.  
There are many design flaws in this research, such as lack of control groups, potential 
confounding factors, inclusion of non-clinical patients and a small number of subjects.  However, 
on balance, the research is encouraging and suggests exercise is an effective treatment for 
depression.  (Greist et al. 1979; North et al. 1990; Lawlor et al., 2001; Craft et al., 1998; 
Martinesen 1990; Mutrie, 2000) 
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1.1 RATIONALE 
Dehydroepiandrosterone (DHEA) is an adrenal steroid that is released during periods of stress.  
It is secreted episodically and in synchronization with cortisol in response to stress.  It has been 
shown to have antiglucocorticoid and antiglutamatergic effects in several tissues, including the 
brain.  Peripherally produced DHEA is thought to be a major source of brain DHEA (Browne et 
al. 1992).  DHEA can also be found in a conjugated form as a sulphate ester, DHEAS.  DHEAS 
is present in higher concentrations and can be thought of as a reservoir and precursor of DHEA.  
The physiological role for DHEA remains unclear and a deficiency state has never been 
described (Ebeling 1994).  Within the brain, regionally specific metabolism of DHEA may 
ultimately control the nature of DHEA’s effects on cognition and behavior (Rose et al. 1997).  
There is evidence that DHEA promotes psychological resilience.  A negative association 
between plasma DHEA levels and depressive symptoms has been reported.  In addition, DHEA 
has been shown to have an antidepressant effect and has been used to treat major depression 
(Goodyer 1998, 2001; Young 2002, Wolkowitz et al. 1999).  Evidence exists that exercise 
increases the plasma levels of DHEA (Baker 1982; Keizer 1987).  Therefore, it follows that if 
exercise results in an acute increase in DHEA this may be an effective treatment modality for 
relieving depressive symptoms.  This potential neuroendocrine mechanism has not been studied 
in patients with bipolar disorder.     
In summary, it is known that 1) DHEA and DHEAS levels appear to be lower in depressed 
people when compared to otherwise psychologically healthy individuals; 2) DHEA and DHEAS 
increases in response to exercise in healthy individuals; and 3) exercise reduces symptoms of 
depression.  The acute effect of aerobic exercise on the hormonal (DHEA / DHEAS) response of 
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patients with bipolar disorder has not been documented.  If DHEAS levels are positively affected 
by acute exercise, this finding may have a significant impact on the treatment of patients with 
bipolar disorder.  Therefore, this investigation will examine serum DHEAS levels immediately 
before and after an acute bout of aerobic exercise in patients with bipolar disorder.   
1.2 STATEMENT OF THE PROBLEM 
The primary goal of this project is to document the DHEAS response to aerobic exercise in 
patients with bipolar disorder.  In addition, the impact of aerobic exercise on perceptions of 
global well-being will be evaluated in this population.  
1.3 HYPOTHESIS 
An acute bout of aerobic exercise will significantly increase DHEAS in patients with clinically 
diagnosed bipolar disorder.  
Sub-hypothesis 
An acute bout of aerobic exercise will significantly improve perceptions of well-being in 
patients suffering from bipolar disorder. 
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2.0  DEPRESSION/BIPOLAR DISORDER AS A PROBLEM 
Bipolar disorder, also known as manic-depressive illness, is a psychological disorder that causes 
unusual changes in one’s energy, mood, and ability to function.  Many healthy individuals go 
through normal emotional highs and lows, however the symptoms of bipolar disorder are 
different.  Symptoms are more severe and can result in poor school or job performance, damaged 
relationships and even suicide.  The economic lifetime cost of the disorder is estimated to range 
from $11,700 per person for mild cases to over $624,000 per person for non-responsive and/or 
chronic cases (Begley et al, 2001). 
More than 2 million American adults (Narrow, 1998), or about 1 percent of the 
population over the age of 18, have bipolar disorder.  Looking at a wider definition of bipolar 
disorder, the occurrence increases to nearly 5% of the population.  Bipolar disorder typically 
develops in late adolescence or early adulthood.  Similar to diabetes or heart disease, bipolar 
disorder is a long-term illness that must be carefully managed throughout a person’s life.   
Dramatic mood swings range from overly happy to irritable to sad and hopeless.  Severe 
changes in energy and behavior go along with changes in mood.  A typical manic episode could 
include any of the following symptoms:  increased energy, activity and restlessness, excessively 
high euphoric mood, irritability, racing thoughts and quick speech, distractibility, little sleep, 
unrealistic beliefs in one’s ability or power, poor judgment, spending sprees, increased sex drive, 
abuse of drugs, provocative or aggressive behavior, and denial that anything is wrong.  The 
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manic phase is often followed by an episode of depression, which has the same symptomology as 
unipolar depression.  These symptoms include, but are not limited to:  feelings of sadness, 
anxiousness, empty mood, hopelessness, pessimism, feelings of guilt, worthlessness, 
helplessness, loss of interest in activities once enjoyed, decreased energy, difficulty 
concentrating, remembering, making a decision, restlessness, sleeping too much, change in 
appetite or unintended weight loss or gain, chronic pain or other persistent bodily symptom that 
is not caused by physical illness and thoughts of suicide or death (DSM IV APA, 2000). 
To date, diagnosis of bipolar disorder cannot be made based on physiological variables.  
Therefore, a diagnosis must be made on the basis of symptoms.  Bipolar is typically diagnosed 
when a manic episode of elevated mood occurs with three or more of the other symptoms most 
of the day, nearly every day for one week or longer.  The manic episode is then followed by a 
depressive episode.  This means the patient has five or more symptoms of depression most of the 
day, nearly every day for a period of 2 weeks or longer (Spearing, et al., 2002). 
Episodes of mania and depression usually recur across the life span.  Between episodes, 
many people with this disorder are relatively free of symptoms.  However, as many as one-third  
of the bipolar population suffers from some residual symptoms and a small percentage of people 
experience chronic unremitting symptoms despite treatment (Hyman et al., 2000).  
Bipolar I is the classic form of the illness and is characterized by recurrent episodes of 
mania and depression.  Some people never develop severe mania but experience milder episodes, 
termed hypomania, that alternate with depression.  This form of the illness is called bipolar II 
disorder.  If more than 3 episodes of illness happen in a 12-month period, a person is said to have 
a rapid-cycling pattern.  Some people have multiple episodes within a single week, or even 
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within a day.  Rapid cycling tends to develop later in the course of the illness and is more 
common among women than men  (Spearing 2002). 
Studies are currently being done to clarify possible causes of bipolar disorder.  Most 
scientists now agree that there is no single cause of the disorder; rather many factors that act 
together to cause the disease.  Bipolar disorder tends to run in families.  Therefore, recent 
research has focused on uncovering genes that may be contributing factors.  However, genes are 
not the entire story; research has shown that if one identical twin suffers from bipolar disorder, 
the other twin is not necessarily affected (NIMH Genetic Workgroup 1998).  This suggests that 
while genes play a role, other factors may be involved in the etiology of bipolar disorder. 
2.1 CURRENT TREATMENT FOR BIPOLAR DISORDER 
Bipolar disorder is a recurrent illness, so long-term preventative treatment is strongly 
recommended and almost always indicated.  A strategy that combines medication and 
psychosocial treatment is optimal for managing the disorder over time.  Research has shown that 
people with bipolar disorder are at risk of switching into mania or hypomania or of switching 
between depression and mania multiple times per day, during treatment with antidepressant 
medication (Thase 2000).  Therefore, “mood-stabilizing” drugs generally are required, alone or 
in combination with antidepressants.  In general, people with this disorder continue treatment 
with mood stabilizers for extended periods of time, many needing the medication for a lifetime.   
Lithium and Valproate are the most commonly prescribed mood-stabilizing drugs.  
Research continues to evaluate potential alternative therapies, as medications have known side 
effects, including: weight gain, nausea, tremor, reduced sexual drive, anxiety, hair loss, 
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movement problems and dry mouth.  Lithium treatment works primarily to ease the manic phase 
of bipolar disorder, but is less effective in relieving the symptoms of depression.  It may cause 
low thyroid levels in some people resulting in the need for further medication supplementation.  
Other medications are added when necessary, typically for shorter periods to treat episodes of 
mania or depression that break through despite the mood stabilizer. 
2.2 CO-MORBIDITIES TYPICAL IN BIPOLAR DISORDER  
Patients suffering from bipolar disorder are at higher risk for developing additional diseases.  
Antipsychotic drugs increase the risk of weight gain, hyperlipidemia and glucose dysregulation.  
Changing or combining medications may be sufficient in some cases, but many times additional 
drugs are needed.   
The risk of developing diabetes is significantly increased in subjects with bipolar disorder 
(Cassidy et al 1999), however, this is only partially accounted for by medications (Henderson 
2002, Baptista 2002).  Atypical and traditional antipsychotics have been shown to impair glucose 
and lipid metabolism (Baptista 2001, Henderson 2002).  Therefore, while the mood disorder 
symptoms may be relieved by pharmacological interventions, other negative health outcomes 
may occur.  After an extended period of time, the bipolar patient may become diabetic, glucose 
intolerant, obese or display high tryglycerides and/or cholesterol.  The question then becomes; 
what is the preferred method of treatment?  Leaving the client in an unmedicated, bipolar state 
may be dangerous due to the high risk of suicide and/or other high-risk behaviors.  Conversely, 
medicating the client with antipsychotic medication may increase the risk for developing other 
chronic diseases.     
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2.3 EXERCISE AS AN ALTERNATIVE TREATMENT FOR MENTAL ILLNESS 
 Exercise has many proven physical and mental health benefits.  Physically fit individuals 
typically experience less stress when engaged in activities of daily living.  A regular program of 
aerobic exercise may lead to an improved immune system, decreases in body weight and body 
fat, reduced cholesterol, increased levels of HDL cholesterol, etc.  However, due to the 
complexity and variability of diseases associated with a sedentary lifestyle, there may be no 
single minimal dose of exercise that is protective for all potential clinical conditions (Balady, et 
al.2000). 
In 1987 the US National Institute of Mental Health (NIMH) assembled a panel of experts 
to produce a consensus statement on the mental health effects of exercise and thus reconcile 
research and clinical practice.  The results concluded that exercise (i) is positively linked with 
mental health and well being, (ii) reduces stress and state anxiety, and (iii) has emotional benefits 
for all age groups and in both genders (Morgan et al., 1988). 
Running has been advocated as a more effective antidote to depression than 
psychoanalysis (Greist et al. 1979).  Research shows that exercise may have an antidepressant 
effect in healthy individuals (North et al. 1990), and among those with multiple mental 
disabilities (Green et al. 1999).  Schizophrenia is one of the most disabling of all mental 
illnesses. Exercise is shown to reduce auditory hallucinations, raise self-esteem, and improve 
sleep patterns and general behavior in schizophrenics (Faulkner et al 1999). 
North et al (1990) reviewed the results of narrative and meta-analytic literature reviews 
investigating the effects of exercise on depression.  The authors suggest that the positive impact 
of exercise on depression could be linked to changing people’s daily routine, increasing 
interactions with other people, helping with weight loss and weight management, participating in 
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outdoor recreation and mastering difficult physical and psychological challenges.  Biological 
factors may also explain, in part, the benefits of exercise on depression.  Research shows that 
exercise promotes the secretion of neurotransmitters like serotonin (Ransford 1982, Morgan 
1985).  Also, evidence from animal studies suggests exercise stimulates the secretion of 
endogenous morphines and produces a state of euphoria (Pert et al. 1979).  This review (Pert et 
al. 1979) also reported that the effects of an acute bout of exercise might be different than 
habitual exercise; however both have effective antidepressant effects.  In general, subjects who 
were the most physically and psychologically unhealthy at the onset of the studies showed the 
greatest improvement following participation in an exercise program.   
Exercise has been shown to produce a significant decrease in depression symptoms when 
compared with no treatment (Lawlor et al.,  2001).  Craft and Landers (1998) conducted a more 
recent meta-analytical review of studies that investigated the effects of exercise on depression 
and mental illness.  All participants in these studies had a clinical diagnosis of depression, either 
as the primary or secondary disorder as the result of mental illness.  Results from 30 studies 
showed an overall effect of -.72, indicating that individuals who exercised were less depressed 
than their sedentary counterparts.  This analysis supports North’s earlier findings that individuals 
who suffered more severely from depression benefited the most from exercise.  Several other 
reviews have shown an inverse relationship between exercise and clinical depression scores 
(Martinsen 1994; Mutrie, 2000). 
Past studies have shown that significant improvements in mood state can be achieved in 
clinically depressed patients following as little as five weeks of exercise training.  Also, follow 
up assessments have indicated that treatment gains can be maintained for up to one year, 
especially when activity was maintained (Doyne et al., 1987; Greist et al., 1979).  Most 
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impressively, exercise has been shown to be four to five times more cost-effective than 
traditional treatments for depression (Freemont et al., 1987; Greist et al., 1979). 
Understanding the symptomology associated with this psychological disorder, questions 
arise regarding exercise compliance.  The efficacy of this treatment intervention is questionable 
given that adherence to exercise may be problematic in this clinical cohort.  Therefore, it is 
important to compare patient perceptions about the usefulness of traditional treatments (i.e. 
medication and psychotherapy) to perceptions of exercise therapy.  Pelham and Campagna 
(1991) reported that psychiatric outpatients, who participated in a 12-week exercise program, 
expressed positive views of exercise.  Moreover, antidepressant, mood-elevation, moderate 
anxiety-reduction, increased self-esteem and improved concentration were some of the described 
benefits.  Martisen and Medhus (1989) found that patients in an exercise group ranked physical 
fitness training as the therapeutic element that had helped them the most.  Patients in the control 
group ranked individual psychotherapy as most important.  Collectively, these studies indicate 
that patients perceive exercise as a useful strategy in their rehabilitation.  In Greist’s study (1979) 
it was noted that the subject dropout rate for depressed runners was 11%.  In contrast, healthy 
runners had a dropout rate of 30-70%.  This gives strength to the theory that mentally ill 
individuals who reap medical benefits from exercise may be more likely to continue the activity. 
2.4 TIMELINE OF RESEARCH 
Research involving the impact of exercise on psychological variables is extensive, with over 
1,000 reports published by 1984.  Results of these studies show a mixture of outcomes.  Many of 
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these studies were done on non- clinically diagnosed depressed patients, which may have had an 
affect on data outcomes (Tkachuk et al., 1999). 
In 1981 Folkins and Sime concluded that many past articles regarding exercise and 
depression had significant methodological shortcomings.  Only 15% were experimental, and 
60% were pre-experimental in design.  They recommended that future research should include 
experimental controls, accurate documentation of duration and intensity of exercise, and 
measurement of cardiovascular function.  
Tkachuk and Martin (1999) reviewed more recent research dealing with exercise in the 
treatment of psychological disorders.  A consistent finding was that exercise was an effective 
primary or adjunctive treatment for mild to moderate depression.  Aerobic exercise has been 
found to be more effective than placebo control conditions and no-treatment conditions (Doyne 
et al. 1983; McCann et al., 1984; Sime 1987). Compared to psychotherapy, exercise has been 
shown to be equally effective in reducing depressive symptomology  (Greist et al., 1979; Harris, 
1987; Martinsen et al., 1985; Freemont et al., 1987, Craft et al., 1998).  Conventional treatments, 
such as psychotherapy and medication, are costly and time consuming with many potential side 
effects.  In comparison, exercise is relatively inexpensive and may have secondary, global health 
benefits.   
2.5 THEORIES OF POTENTIAL MECHANISMS 
There are many hypothesized mechanisms by which exercise is thought to influence mental 
health.  Various biological, psychosocial and psychological models and theories have been 
developed that may help explain this proposed relationship.  It is unlikely that any single 
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mechanism accounts for the exercise and mental health relation.  Further research should address 
each of the following potential explanations.   
2.5.1 Psychosocial/Psychological Mechanism Theories 
Many proposed explanations by which exercise may influence mental health focus on 
mechanisms involving psychosocial or psychological rationales.  Individual theories are 
described below.   
2.5.1.1 Self Esteem Theory 
There is an established link between depression and negative self-evaluation, including low self-
esteem (Leary 1995; Roberts 1997) and self-efficacy (Bandura et al, 1999).  It is hypothesized 
that effective depression interventions are successful in part, by improving self-evaluations.  
Research suggests that exercise increases overall self-esteem (Bosscher 1999; Ossip-Klein  et al, 
1989), exercise self-efficacy (McAuley et al 2000), body image (Bosscher 1999; McAuley et al., 
2000) and physical self-worth (McAuley et al. 1997).  This suggests that the antidepressant 
effects of exercise may be mediated by improved self-evaluations. 
2.5.1.2 Mastery Theory 
Sondstroem’s (1978) model for physical activity assumes that involvement in activity increases 
physical ability.  As individuals take pride in their bodies, they continue to exercise, thereby 
maintaining or increasing fitness.  More physical activity leads to higher perceptions of physical 
ability and self-esteem, which results in even more attraction to physical activity; thus continuing 
a positive cycle.  
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2.5.1.3 Distraction Theory 
The distraction theory was originally conceptualized by Bahrke & Morgan (1978) in a study that 
compared anxiety level between walking on a treadmill, meditating or resting in a chair.  They 
found all three groups decreased levels of anxiety after treatment.  They concluded that exercise 
could serve as a distraction from stressful stimuli.  Later research showed that exercise distracts 
subjects from less favorable analytical thoughts (Just, 1997; Nolen-Hoeksema et al., 1993).   
2.5.1.4 Behavioral Activation 
Exercise may serve as a behavioral activation, which is a key component of Cognitive 
Behavioral Psychotherapy (Hollon 2001).  Behavioral activation can be described as a 
therapeutic process that emphasizes structured attempts to encourage involvement with 
rewarding experiences.  This produces corresponding improvements of mood and thought 
patterns.  Improvement of mood leads to further interaction with experiences creating a decline 
in depressive symptoms.     
2.5.1.5 Social Reinforcement 
Others have theorized that beneficial effects of exercise are the result of social reinforcement that 
new participants may receive from the activity (Hughes 1984).  Depression often leads to self-
isolation.  Isolation leads patients to miss out on positive social exchanges that could potentially 
relieve symptoms of their disease.  Studies that incorporate group or supervised activity 
introduce a social component that would, for many clients, otherwise not exist.   
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2.5.2 Biological Mechanism Theories 
Many proposed explanations by which exercise may influence mental health focus on biological 
mechanisms.  Individual theories are described below.   
2.5.2.1 Hyperthermic Model 
The hyperthermic model suggests that the elevation in body temperature during exercise is the 
stimulus for relieving depressive symptoms.  The alteration in psychological state is theoretically 
manifested in many responses that are managed by the hypothalamus.  The belief that elevating 
body temperature can be therapeutic is longstanding.  Research has shown that total body 
warming reduces muscle tension (DeVries et al, 1968).  Later in a counterbalanced design, high 
intensity exercise and passive heating produced similar increases in slow wave sleep (relaxation 
effect) and that exercise may be a vehicle for those effects (Horne et al. 1983).  Support for this 
theory has been mixed.  There are many studies that have failed to show a positive relationship 
between temperature increase, exercise and psychological states.  It is now thought that there are 
more comprehensive models that better explain the relationship between exercise and depression 
(Daley, 2002).  Temperature and mood regulation are also postulated to be linked through the 
circadian rhythm system.  
2.5.2.2 Endorphin Hypothesis 
It is hypothesized that the euphoria that often accompanies an acute bout of exercise is caused by 
the production or release and subsequent binding of endogenous opiods to receptor sites in the 
brain (Steinberg et al., 1985).  Research on rat brain tissue suggests that significant increases in 
opiate receptor occupancy occur after exercise (Pert et al., 1979; Wardlaw et al., 1980).  In 1982, 
Christie and Chesher demonstrated that mice became addicted to swimming, if they exercised 
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regularly.  Because of the inherent problems of examining endorphin receptor site occupancy in 
human brains, research has attempted to quantify endorphin levels after exercise in peripheral 
locations outside of the blood-brain barrier.  Farrel (1989) suggested that exercise does not alter 
the blood-brain barrier in a way that allows peripheral endorphins to act directly upon the brain.  
The blood-brain barrier impedes the movement of opiate substances from the blood to the brain.  
Therefore, the exercise induced increase in beta-endorphins may not be responsible for the 
“euphoria” secondary to exercise.  However, given the difficulty in measuring the concentration 
of endorphins in the cerebral spinal fluid, this theory is difficult to test.    
2.5.2.3 Central Monoamines 
Serotonin, noradrenaline and dopamine, have long been implicated in the etiology of depression 
(Delgado, 2000; Hirschfeld 2000).  Current theories emphasize the complexity of the role of 
monoamines on the functioning of specific brain regions (Klimek et al., 1997) and in treatment 
of subsets of depressed patients (Charney 1998; Schatzberg 1998).  If abnormal levels of 
monoamines are responsible for depression, it follows that depression could be treated by 
normalizing monoamines.  There is experimental evidence that supports this hypothesis.   
Animal studies have suggested that exercise affects the central nervous system 
noradrenaline levels and metabolism (Dunn et al. 1996) in general.  They also show specific 
brain regions are associated with stress reactivity (Dishman 1997) and learned helplessness 
(Dishman et al. 2000).  In humans, plasma data provide poor estimates of central nervous system 
(CNS) amine levels, however some studies did find that exercise is associated with increases in 
plasma monoamine levels (Chaouloff, 1997; Weicker 2001).  Also, research indicates that 
exercise increases the concentration of free fatty acids and free tryptophan levels.  This may lead 
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to an increased rate of serotonin synthesis by increasing CNS availability of amino acid 
precursors (Blomstrand et al. 1988). 
2.5.2.4 Imbalance in Hypothalamic-Pituitary-Adrenal Axis (HPA) Functioning 
Prior to describing the imbalance in the HPA axis, it is important to first explain the normal HPA 
functioning.  Research is beginning to show that the HPA axis may be thought of as the body’s 
energy regulator. It is ultimately responsible for controlling virtually all of the hormones, 
nervous system activity and energy expenditure in the human body, as well as modulating the 
immune system.  
When the body is exposed to a stressor, the adrenal cortex releases cortisol.  Multiple 
processes control the execution of cortisol release.  First, the paraventricular nucleus (PVS) of 
the hypothalamus ultimately has control of the cortisol release.  The hypothalamus will release 
corticotropin-releasing hormone (CRH) when a stress occurs.  CRH then acts on the pituitary 
gland, which in turn, stimulates the release of adrenocorticotrophic hormone (ACTH).  ACTH 
causes the adrenal cortex to release cortisol.  CRH and ACTH are released in short pulses, each 
of which causes roughly a 15 minute sustained release of cortisol from the adrenal cortex with a 
half-life of approximately 100 minutes in the blood.  Prolonged release of ACTH causes the 
adrenal cortex to increase in size, presumably to cope with the larger need for cortisol 
production.  In contrast, long-term ACTH deficiency causes the adrenal cortex to shrink.  
Negative and positive feedback mechanisms ensure that cortisol production stays within certain 
physiological limits, depending on a person’s current requirements and stress level (Tipperman 
1980). 
Similar to the central monoamine theory, imbalances in HPA axis functioning have been 
linked to depression.  It is well established that depressed patients tend to have higher baseline 
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basal cortisol levels (Akil et al, 1993; Lesch et al. 1988).  Depression is generally marked by 
hyperactivity of the HPA axis and exercise training can lead to an attenuation of the axis 
response to stress.  Dienstbier (1991) summarized the results of several studies by stating that 
exercise training resulted in physiological “toughness” marked by a delay in the HPA axis 
response to stress.  Research in humans has been largely consistent with this model.  Exercise-
trained humans exhibit a hyposensitive HPA axis response to an exercise challenge (Wittert GA 
et al, 1996) and mental stress (Blumenthal et al. 1991). 
2.5.2.5 Allostatic Load Theory 
Allostasis was originally referred to by Sterling and Eyer (1988) who defined it as a 
physiological process involved in the adaptation to acute stress.  It was described as the process 
of the internal environment adapting to meet the perceived and anticipated demand.  McEwen 
(2002) expanded this theory to include the concept of a set point that changes because of the 
need to maintain homeostasis.  The hormonal response to a threat may promote survival in the 
short term.  However, if recovery from the acute event is incomplete, elevated resting levels of 
stress hormones may have a profound impact on psychological and physiological function 
resulting in an “allostatic load”.  This concept links the protective and survival values of acute 
responses to stress to the adverse consequences of chronic stress.  Identification of techniques to 
lower the psychobiological allostatic load could provide insight into improved methods to 
prevent and treat mental disorders.   
Many neurotransmitters, neuropeptides, and hormones have been linked to the acute 
psychobiological response to stress and the long-term psychiatric outcome.  The roles of these 
neurotransmitters, neuropeptides, and hormones have been shown to be altered by stress and 
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have important functional interactions.  They mediate neural circuits relevant to regulation of 
reward, fear conditioning, and social behavior.   
Cortisol, Dehydroepiandrosterone, CRH, the locus coeruleus-norepinephrine system, 
neuropeptide Y, galanin, dopamine, serotonin, benzodiazepine receptors, gonadal steroids and 
estrogen are all implicated as being contributors, alone or through interaction, to resilience to 
stress.  The hypothesis of allostatic load also states that the cumulative effect of modest 
dysregulation in multiple systems could be substantial, even if independently they have minimal 
impact on health.  
2.6 DEFINING DHEA 
Dehydroepiandrosterone, (DHEA) is a 19-carbon steroid hormone that is classified as a weak 
androgen (Herbert 1995).  DHEA also is known as a prohormone, as it is a precursor of more 
potent sex hormones.  DHEA, is found in the circulation in two forms, one unconjugated 
(DHEA) and the other conjugated as its sulphate ester DHEAS.  DHEAS is present in a higher 
concentration than DHEA.  DHEAS can be thought of as a reservoir and precursor of DHEA, 
since the interconversion rate between them is high (Longcope 1996).  DHEAS concentrations 
are particularly high in the brain, (Baulieu et al, 1998; Dubrovsky 1997).  DHEA and DHEAS 
can penetrate the blood brain barrier (Baulieu et al, 1998) and act as an inhibitor of gamma-
amino butyric acid (GABA) receptors.  More current research suggests that the only source of 
brain DHEAS may be from the periphery, specifically the adrenals and gonads (Compagnone, 
2000). 
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DHEAS is the most abundant circulating steroid hormone in the body (Herrington 1998) 
and has a very high turnover rate, which suggests that it is a biologically active hormone.  A 
physiological role for DHEAS remains unclear and a deficiency state has never been described 
(Ebeling 1994). 
Metabolism of DHEA and DHEAS differ.  DHEA circulates in the blood bound mainly 
to albumin with only minimal binding to globulin.  A small amount of DHEA circulates freely.  
DHEAS, is more strongly bound to albumin, none is bound to globulin, and a small amount is 
free (Longcope 1996).  DHEA, but not DHEAS, has a circadian rhythm related to the secretion 
of adrenocorticotrophic hormone (ACTH) (Liu, et al. 1990).  DHEA falls considerably during 
three hours post awakening but remains stable after that.  DHEAS has a long half-life in the 
circulation and exhibits little circadian rhythmicity (Goodyer at al., 1996).   
It appears that DHEA and DHEAS levels provide a constant and stable index of 
underlying adrenal steroidogenic capacity (Wuest et al., 2000).  Individual differences in levels 
of DHEA and DHEAS seem robust and consistent (Hucklebridge, 2005). 
The effects of DHEA are complicated, as it is hard to assess whether actions can be 
attributed to DHEA, its metabolites, or a combination of both.  DHEA effects appear to be 
gender specific.  In addition, DHEA may differentially affect women based upon their 
menopausal status.  The age of person also has an impact on the action of DHEA (Regelson, 
1994). 
In humans, DHEA and DHEAS levels in the fetus are high, but the secretion decreases 
soon after birth and remains low until the adrenarche (Hopper, 1975) when it peaks around ages 
20-25 years.  The concentrations of DHEA and DHEAS then decline at a rate of about 10% per 
decade to values of 20% to 30 % of peak at approximately 70 to 80 years of age.  This age 
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related decrease has lead clinicians to promote DHEA as therapy for the cognitive impairment 
associated with aging.  Results of clinical trials, which lasted from 3 to 12 months, suggested 
such a role was possible.  (Morales, et al 1994; Morales, et al 1998)  
Browne, et al (1992) suggested that DHEA and/or DHEAS may act as antagonists of 
glucocorticoids.  The finding that healthy persons with high ACTH-releasing hormone and 
cortisol responses to exercise exhibit higher baseline levels of DHEA and DHEAS suggests that 
DHEA might enhance the hypothalamic-pituitary-adrenal response to exercise.  (Deuster 2005)  
2.6.1 DHEA/DHEAS AND MENTAL ILLNESS 
DHEA has been thought to play a role in multiple medical and psychological disorders.  Levels 
of DHEA have been shown to be lower in individuals with type II diabetes, coronary artery 
disease and rheumatoid arthritis (Masi, 1995). Similarly, low levels have also been noted in 
individuals with chronic fatigue syndrome (Scott 1999). DHEA has been shown to be low in 
subjects who suffer from depression (Michael, 2000; Wolkowitz, 1997; Goodyer 1996), anorexia 
(Zumoff et al, 1983) and schizophrenia (Oades 1994).  As a generalization, reduced levels of 
DHEA have been found in most of those disorders thus far been reported (Figure 1), although 
that finding does not prove that it is causal (Corrigan, 2002). 
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Figure 1 DHEA in Healthy vs. Mentally Ill Subjects 
 
Yen, et al, reported an increase in physical and psychological well being associated with 
DHEA supplementation (Yen, et al. 1995).  However, most of the evidence for supplementation 
is extrapolated from animal studies and there is little consensus as to the benefits of DHEA 
replacement therapy in humans (Hinson 1999).  Physical and psychological improvement in 67% 
of men and 84% of women has been found secondary to DHEA supplementation.  Improvement 
in memory and cognitive functions has been suggested, but results in general have been 
somewhat disappointing (Barrett-Connor, 1994; Rudman 1990).  It still remains to be proven if 
the changes secondary to DHEA supplementation are beneficial to the aged population (Huppert 
2000).  DHEA and DHEAS levels decline in Alzheimer’s disease unrelated to age (Sunderland, 
et al. 1989) but this decline is not necessarily linked to the cause of the disease (Schneider 1992). 
DHEA may modulate insulin output in men and women (Mortola, 1990; Nestler, 1992) 
and therefore may have an antidiabetic effect (Nestler, 1992).  Men with low levels of 
testosterone may also have low levels of DHEAS and insulin resistance (Haffner, 1994).  
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Postmenopausal women given 50 mg of DHEA a day showed enhanced insulin sensitivity and 
lower blood triglycerides (Casson, 1993). 
Coyle and Manji (2002) have hypothesized that cellular resilience may be limited, which 
leads to neuronal vulnerability to ischemia and hypoglycemia.  This hypothesis is a result of the 
neuronal decline associated with stress and glucocorticoids.  This may help unravel the mystery 
of mood episodes and recurring stress, as seen in bipolar subjects.  DHEA, as a known 
antiglucocorticoid, naturally may reverse the affects of glucocorticoids on the human system.   
2.6.2 DHEA AND EXERCISE 
Previous studies generally have shown that DHEA and DHEAS levels increase in response to 
exercise.  Significant elevations in DHEA have been found in women who have completed a 10-
mile run (Baker 1982) and following treadmill running (Keizer 1987).  In 1997, Johnson et. al 
saw an elevation in DHEA with a 30 minute treadmill exercise bout at 80% of VO2 max in 
postmenopausal women . 
Dressendorfer et. al (1991) found that DHEA levels increased, although not significantly, 
over a 15 day endurance bike race.  The subjects were all trained, healthy individuals and DHEA 
was measured after 20 hours of recovery.  During marathon running, healthy individuals showed 
a non-significant rise in DHEA levels as well (Ponjee, 1994).  Baker’s study (1982) suggested 
that DHEA concentrations are higher among trained individuals when compared to untrained 
controls.  Cumming and Rebar (1983) documented increases in DHEA concentrations in 
untrained and trained women in response to a graded exercise test. 
In 2004, Tremblay studied the effects of acute bouts of aerobic and resistance exercises 
on DHEA in trained and sedentary individuals.  This study found that DHEA increased with 
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resistance and aerobic exercise, although the response was greater after resistance exercise than a 
run.  The exercise that elicited the longest levels of DHEA elevation proved to be resistance 
exercise in resistance-trained subjects.  This contradicts Hakkinen’s findings (2000) that saw no 
change in DHEA after resistance exercise in elderly men.   
2.6.3 RESPONSES OF DHEA AND CORTISOL DUE TO MEDICATION 
Bipolar subjects are rarely clinically diagnosed and non-medicated.  This issue forces 
investigation of medication on DHEA.  In a study done by Assies et al (2004), DHEA and 
DHEAS seemed to be a more sensitive indicator of depression and symptom severity than 
cortisol in medicated but still clinically depressed patients.  This indicates that medication may 
have little or no effect on DHEA and DHEAS production.  However, significant and strong 
inverse associations between DHEAS and the number but not with any specific type of 
medications have been observed.  (Ravaglia et al., 2002)  Therefore, medications could be a 
confounding factor in the present research.  Since the number of medications may influence 
baseline DHEAS levels, it follows that medications could have an impact on the amount of 
DHEAS change in response to exercise.   
2.7 SUMMARY 
Exercise has long been used as a means of preventing disease and promoting health and well-
being.  A great deal of scientific evidence supports exercise as being beneficial to mental health.  
These benefits include a reduction in anxiety, depression and negative mood.  There are significant 
reports’ showing that exercise improves self-esteem and cognitive functioning, yet, exercise is 
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seldom recognized by mainstream mental health services as an effective intervention in the care 
and treatment of mental health problems, specifically bipolar disorder.  Exercise may well be an 
important but neglected intervention in mental health care. 
Many studies have shown positive changes in mood state in response to exercise.  However 
the causes of these improvements in mood remain unclear.  While many of these studies suggest 
that there could be a physiological reason for the change, psychological factors such as increased 
socialization or goal accomplishment cannot be excluded as viable explanations.  To our 
knowledge, no study has examined the change in DHEA or DHEAS in response to exercise in 
mentally ill subjects.  If DHEAS levels in bipolar subjects are shown to increase following sub-
maximal exercise, a profound impact in the treatment of mood disorders could be expected.    
Ultimately, it is hoped that this inquiry may lead to the incorporation of an exercise routine as part 
of the treatment for bipolar patients.  Exercise, unlike many medications, has no negative side 
effects and a wide range of positive outcomes when prescribed and applied correctly.  
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3.0  METHODS 
 
A review of related literature has demonstrated the following:  1) bipolar disorder is an economic 
and medical concern in the United States today, 2) current pharmacological treatment and 
behavioral therapy for bipolar disorder is not refined to a perfect solution, 3) exercise has been 
shown to reduce symptoms of various types of mental illness 4) several theories have linked 
Dehydroepiandosterone (DHEA) and its sulphate ester (DHEAS) to depression and other mental 
disorders 5) an acute bout of exercise may change DHEAS levels which may cause a reduction in 
the depression symptoms seen in bipolar disorder. 
Despite the findings that exercise may play a significant role in reducing the symptoms of 
bipolar disease, clinicians rarely include exercise as part of their treatment plan. The goal of this 
investigation is to better understand the impact of an acute bout of exercise on DHEAS levels in 
bipolar patients.  This information may be the basis for the use of aerobic exercise instead of or 
in conjunction with the current standard treatment, which typically involves prescription 
medications.  Information generated in this investigation may lead to improved treatment 
outcomes, decreased costs associated with the disorder, and improved health of patients.   
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3.1 SUBJECT POPULATION 
Male and female outpatients, aged 18-65 years who were participants in the Bipolar Disorder 
Center for Pennsylvanians (BDCP) and who had been diagnosed with Bipolar Disorder served as 
subjects for this investigation.  The racial, gender, and ethnic characteristics of the subject 
population reflected the demographics of Pittsburgh and the surrounding areas and/or the patient 
population of the University of Pittsburgh Medical Center.  No exclusion criteria were biased on 
race, gender, or HIV issues.   
Patients were asked by their primary BDCP psychiatrist to participate in this study if the 
psychiatrist believed an exercise session would be appropriate for that individual.  Some 
participants of the BDCP suffered from other mental co-morbidities, such as panic disorder or 
severe anxiety.  The treating psychiatrist concluded this study to be over stimulating and 
inappropriate for such patients. 
Appropriate physician referrals were forwarded to the primary investigator, who contacted 
potential subjects to discuss participation in the study. 
When a power analysis was run, it was determined that 27 subjects were needed to 
achieve statistical significance at p < .05 with a medium effect size. 
3.1.1 Inclusion Criteria 
1. Provided written informed consent before enrollment and any study-specific procedures 
were conducted. 
2. Male and female patients between 18-65 years of age. 
3. Met DSM-IV criteria for Bipolar I or Bipolar II disorder. 
4. Outpatient status. 
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3.1.2 Exclusion Criteria 
1. Women who were pregnant. 
2. Previous occurrence of myocardial infarction. 
3. At time of study receiving Beta Blocker treatment. 
4. Type I or Type II diabetic. 
5. Unable to perceive performing aerobic exercise of 70% + 5 beats/min of age predicted 
heart rate maximum for a minimum of 30 minutes. 
3.1.3 Recruitment Procedures 
Subjects were referred to the study by their BDCP psychiatrist (Drs. Denko, Spiker, 
Friedman, or Fagiolini) if it was believed that their patient would tolerate exercise.  No cold calling 
occurred. The primary investigator (PI) discussed the research project with the potential subject.  If 
he/she expressed interest in the study, the PI read the prescreening script (Appendix A) to 
determine participant eligibility.  Next, the investigator asked the potential subject the seven 
questions listed on the Physical Activity Readiness Questionnaire (PAR-Q) (Appendix B).  In 
addition to the PAR-Q, all potential subjects completed a medical history questionnaire (Appendix 
C).  Both forms were helpful in determining participant safety and eligibility.  Lastly, a medical 
clearance (Appendix D) was signed by all subject’s primary care physicians which indicated all 
subjects were deemed safe to participate in the exercise protocol.   
The Principal Investigator obtained an informed consent (Appendix E) after the objectives, 
procedures, and a clear explanation of the risks and benefits of the study were presented.  The 
voluntary nature of research participation was clearly explained, as well the alternatives for non-
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research treatment. A copy of the signed informed consent form was given to the patient and the 
original placed in the subject’s research file.  All files were kept in a secured cabinet to maintain 
confidentiality.  All procedures were approved by the Biomedical Institutional Review Board at 
the University of Pittsburgh prior to the start of this study. 
3.2 EXPERIMENTAL DESIGN 
This was an experimental trial with 27 participants.  Baseline measurements included 
body weight, height, body composition, waist to hip ratio, serum DHEAS, resting blood pressure 
and resting heart rate.  All medications taken by the subject were recorded.  This trial consisted 
of subjects walking or jogging on a motor driven treadmill for 20 minutes at an intensity that 
resulted in a heart rate response of 70% +5 bpm of his/her age-predicted maximal heart rate.  
Body composition and body fat distribution analysis was used to help inform the subject of 
his/her current health status and assisted in describing this cohort.  Figure 2 describes the flow of 
testing procedures. 
 
 
 
 
 
 
 
 
Patient referral from Dr. Friedman, Denko, Spiker, or Fagiolini 
PI read pre-screening script (Appendix A) to determine subject 
eligibility 
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Subjects completed PAR-Q (Appendix B) and Medical History Questionnaire (Appendix C) 
Medical Clearance (Appendix D) was obtained from subject’s primary care physician  
Fitness Test was scheduled 
Client arrived on scheduled day to Human Energy Research Lab, Trees Hall, University of Pittsburgh 
Subject read and signed the IRB approved informed consent (Appendix E) 
Experimental procedures were explained (Explanation of Testing Procedures, Appendix F) and 
any subject questions answered  
Likert 7 point scale for well-being was administered (Appendix G) 
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Anthropometric, skinfold, and circumference measurements taken 
2 tubes of blood drawn with one standard venipuncture of an anticubital vein  
 
 
 
Subject were fitted with a Polar Heart Rate 
 
 
 
Resting heart rate recorded (Data Collection Form, Appendix H) 
 
 
 
 
Minutes 0-2: walk at 2.2 mph/ 0% grade 
 
 
 
 
Minutes 2-5: acquisition of heart rate range by increasing speed 
and/or grade 
 
 
 
 
 
Minutes 5-25: exercised at 70% + 5 bpm of age predicted heart rate 
max, BP measured every 5 minutes, heart rate measured every minute 
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Minutes 25-30: returned treadmill to 2.2 mph, 0% grade.   
 
 
 
Subject moved to a seated position until heart rate and blood pressure normalized. 
 
 
Second Likert 7 point scale, identical to the first, administered  
 
 
Second blood draw, identical to the first, conducted 5 minutes 
after the treadmill test was terminated. 
 
 
 
 
Subject were offered juice and/or water and PI reviewed Health 
Summary (Appendix I) 
 
 
 
 
 
Subject paid $25 stipend and escorted out of the building 
Figure 2.  Flow of Testing Procedures 
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3.3 PRE-TEST INSTRUCTIONS   
Prior to scheduling the exercise test, the investigator read the prescreening evaluation script to 
the potential subject (Appendix A).  This script introduced the investigator, screened the subject 
for inclusion and exclusion criteria and also informed the subject of the exercise testing protocol.  
The subject answered the Physical Activity Readiness Questionnaire (PAR-Q) questions 
(Appendix B) and completed the medical history questionnaire (Appendix C).  If the subject met 
the inclusion criteria without meeting any exclusion criteria, an exercise test date was scheduled 
for a time in which the subject would have been awake for a minimum of 3 hours.  Next, the PI 
asked the subject to maintain their regular schedule of eating and medication, asked them not to 
exercise the day prior to or the day of the exam, and asked them not to consume alcoholic 
beverages the day prior to or the day of the exam.  The PI reminded them to wear comfortable 
exercise clothing to the test and to drink plenty of water the day of the exam.    Prior to the 
scheduled exercise test date, the PI obtained a medical clearance from the subject’s primary care 
physician (Appendix D). 
3.4 ASSESSMENT COMPONENTS (DATA COLLECTION FORM APPENDIX H) 
3.4.1 Hours of awake time   
The subject was asked what time he/she awoke on the scheduled test date.  The starting time of 
test was recorded.  This was done to ensure the subject has been awake for three or more hours, 
as requested during the prescreening evaluation.  All subjects indicated they had been awake for 
three or more hours prior to the appointment. 
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3.4.2 Weight   
Subjects wore shorts and a t-shirt.  Subjects were instructed to remove their shoes, jewelry, and 
all objects from their pockets prior to the measurement of body weight.  Body weight was 
measured using a Tanita Bioelectrical Impedance Analysis (BIA) Scale (TANITA TBF-300A 
Body Composition Analyzer, Arlington Heights, IL).   
3.4.3  Height   
Height was measured using a calibrated, scale mounted stadiometer (Detecto, Webb City, MO 
model number 3P7044).  Subjects were instructed to remove their shoes and to stand upright 
with their back and heels of their feet against the scale.  
3.4.4 Body Composition  
An estimate of body composition was determined using a Tanita Bioelectrical Impedance 
Analysis (BIA) Scale (TANITA TBF-300A Body Composition Analyzer, Arlington Heights, 
IL).  The benefits of measuring body composition via BIA include ease of use and speed of 
measurement.    
3.4.5 Regional Adiposity  
Girth measures of the waist and hip were assessed as described by the American College of 
Sports Medicine (Lippincott Williams and Wilkins, 2005).  The waist circumference 
measurement was obtained at the smallest portion of the waist above the umbilicus.  The largest 
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circumference of the hips and buttocks was used as the denominator in the ratio.  A Gulick 
fiberglass measuring tape with a calibrated tension device was used for all circumference 
measurements.  The waste to hip ratio has been shown to correlate with health related risk factors 
in men and women (Depres, et al 1995).   
3.4.6 Resting Heart Rate   
A Polar Heart Rate monitor (model A3, Woodbury, NJ) was used to determine resting heart rate.  
The back of the heart rate sensor was moistened and applied directly to the skin at the xiphoid 
process of the sternum.  The monitor was affixed to the subject with an elastic band to ensure a 
proper skin to sensor interface. The Polar Heart Watch (part of the monitor unit, model A3) 
displayed the subjects’ heart rate and was worn by the subject at his/her wrist.  Resting heart rate 
was recorded after the subject has been seated for 3 minutes. 
3.4.7 Blood Chemistry  
The blood draws were taken from an antecubital vein by a certified phlebotomist while the 
subjects are in a seated position.  Two tubes of blood were drawn with a Vacutainer butterfly 23- 
gauge needle (3/4”), one, a 7.5 ml serum separator tube and the other a sterile 2 ml vacutainer 
that was used to assess Hematocrit. 
  Plasma volume changes were determined from the hematocrit values to control for 
hemoconcentration that could alter hormone levels.  A 2 ml sterile vacutainer was used to collect 
blood for the assessment of Hematocrit.  A capillary tube was inserted into the blood sample and 
blood was drawn into the tube until the graduation mark had been reached.  The capillary tube was 
inserted into critoseal to seal one end of the tube.  Two capillary tubes were obtained for each 
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sample and spun in a centrifuge for 5 minutes.  Hematocrit was calculated using the average of the 
two measures. (Knowlton et al, 1990)  
The serum separator tubes were spun for 30 minutes.  Once the serum was successfully 
separated, the serum was poured into a storage vial and the blood cell, or solid portion of the 
sample, was disposed of in a biohazard container.  DHEAS was analyzed at The University of 
Kentucky’s General Clinic Research Center (GCRC).   
The GCRC asked for all samples to be delivered at the same time.  Therefore, all serum 
samples were collected and frozen at –80 degrees C at the University of Pittsburgh’s GCRC 
located in Montifiour Hospital until data collection was complete.  Upon completion of data 
collection, the samples were sent to the University of Kentucky for analysis in a single batch.   
 The basic principle of DHEAS (dehydroepiandrosterone sulfate) analysis involved a solid-
phase, competitive chemiluminescent enzyme immunoassay.  Serum was used and the usual 
precautions for venipuncture were observed.  Specimens were stored at –80 degrees C until 
analyzed.     
3.4.8 Exercise session   
All exercise tests were conducted in the Human Energy Research Laboratory at the University of 
Pittsburgh by a qualified exercise physiologist.  Room temperature was maintained between 65 
and 72 degrees Fahrenheit.  A target heart rate range corresponding to 70% of the subject’s age 
predicted heart rate max was calculated. The subject was given a brief orientation to treadmill 
walking.  All subjects initially walked on The Trackmaster (model number TMX426C; Newton 
KS) treadmill at 2.2 mph with zero percent grade for 2 minutes.  Next, the exercise physiologist 
titrated the treadmill to the desired speed and grade of the subject that elicited the appropriate 
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heart rate response (70% of age predicted heart rate maximum + 5 bpm).  The subject was asked 
to choose a faster pace or increased incline to increase intensity.  Heart rate was displayed by the 
Polar Heart Watch and monitored every 15 seconds to determine when the subject had reached 
the target heart rate zone.  The correct training speed and grade was identified by the beginning 
of the 5th minute of exercise.  If the correct load had not been selected by the 5th minute, the 20 
minutes of exercise did not begin.  Instead, the next few minutes were used to find the correct 
training load to elicit the required heart rate.  Once the target heart rate has been attained, the 20-
minute exercise bout began.  The client continued to exercise at this pace for 20 minutes.  Heart 
rate was monitored and recorded every minute.  If a subject’s exercising heart rate became out of 
the prescribed range, the investigator changed the speed and/or incline of the treadmill as desired 
by the client until the heart rate was appropriate.  Every five minutes a blood pressure measure 
was taken to enhance subject safety.  ACSM criterion for termination of an exercise test was 
used to establish test end points if necessary (Appendix J). After the subject has exercised in 
their target heart rate range for 20 minutes, the exercise physiologist slowed the treadmill to 2.2 
mph and decrease the grade to 0%.  The subject walked at this stage for 5 minutes.  The subject 
was then moved to a seated position and monitored every minute until blood pressure and heart 
rate normalized.   
3.4.9 Post-Exercise Blood Analysis 
Within five minutes post completion of the cool down phase, a second blood draw, identical to 
the first, occured.  Blood was analyzed for DHEAS and Hct as previously described.   
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3.4.10 Health Summary 
Upon completion of the exam, the primary investigator reviewed the exercise test results with the 
subject.  The PI explained and answered any questions the subject had regarding their 
information.  (Appendix G) 
3.4.11  Likert 7 point scale for perception of global well-being (Appendix F)   
Before the exercise session began and concurrent with the signing of the informed consent form 
and testing instructions, the subject was asked to rate his/her perception of well-being on a 7 
point Likert scale.  This scale consisted of seven options.  The subject rated how they felt at that 
moment in time.  The scale ranged from “severely depressed” to “excessively happy”.  After the 
exercise session was over and health summary form was given, the subject was asked to rate his 
well-being again.  The purpose of this is to assess any change in perception of well-being that 
may have been correlated with the exercise bout.   
3.5 STATISTICAL ANALYSIS  
All analyses were performed using Statistical Packages for the Social Sciences (SPSS version 
7.5).  The type I error rate was controlled at 5% for all analyses (p<0.05).  A Repeated Measures 
ANOVA was used to test for main effects for exercise and gender.  A two tailed, dependant T-
Test was used to analyze changes in perceptions of global well-being.  Lastly, a Pearson 
Correlation was used to assess any potential relationship between DHEAS changes and changes 
in perceptions of global well-being.   
 39 
4.0  RESULTS 
The primary aim of this study was to examine the effect of an acute bout of aerobic exercise on 
DHEAS in clinically diagnosed bipolar subjects.  A secondary aim was to explore changes in 
perceptions of global well-being following exercise and examine the relationship between 
improvement in perceptions of well-being and DHEAS.  Male (n=13) and female (n=13) 
outpatients diagnosed with bipolar disorder served as subjects for this pilot investigation.  All 
subjects were participants in the Bipolar Disorder Center for Pennsylvanians (BDCP) and were 
between the ages of 18 and 65 years.  The racial, gender, and ethnic characteristics of the subject 
population reflected the demographics of the University of Pittsburgh Medical Center.   
No participant reported suffering a myocardial infarction or the presence of diabetes 
mellitus.  No subject was receiving Beta Blocker treatment.  All prospective subjects indicated a 
perceived ability to perform the intended exercise protocol. A total of 27 subjects were tested, 
however one female subject had an immeasurable DHEAS score.  Data from this subject were not 
included in the statistical analysis.  Characteristics of the 26 subjects are presented in Table 1.   
 
Table 1  Subject Characteristics (Mean + standard deviation) 
Gender  Age (years) Height (cm) Weight (kg) Body fat (%)   
Male (n=13)  45.2 + 13.0 176.5 + 5.6 88.9 + 14.9 25.1 + 2.9 
Female (n=13) 39.5 + 9.2 167.4 + 6.4 84.7 + 28.6 35.3 + 11.4 
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4.1 DHEAS RESULTS 
A Repeated Measures ANOVA revealed significant main effects for exercise (p=0.013) 
and gender (p=0.047).  The exercise by gender interaction was not significant.  The summary 
ANOVA table can be found in Appendix K.    
4.1.1 DHEAS and Exercise 
Levels of DHEAS rose from a baseline value of 187.6+152.2 ug/dl to 196.2+158.7 ug/dl 
following exercise.   These results are presented in Figure 3.  Individual DHEAS responses can 
be found in Appendix L. 
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Figure 3.  DHEAS before and after a 20-minute bout of treadmill exercise at a intensity of 70% of age 
predicted maximal heart rate. 
* Significantly different (p=0.013) from pre-exercise 
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 A Bland-Altman plot of DHEAS levels pre and post exercise compared to individual 
change in DHEAS levels is presented in Figure 4.  The solid line indicates mean DHEAS change 
from pre to post exercise.  The dotted lines represent + two standard deviations. 
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Figure 4 DHEAS changes compared with overall mean DHEAS levels 
4.1.2 DHEAS and gender 
Men displayed a significantly (p=0.047) higher level of DHEAS at baseline and after exercise 
when compared to females (Figure 5).  There was no statistically significant difference in the 
amount of change in DHEAS between the men  (10.0+19.5 ug/dl) and women (7.1+12.1 ug/dl).   
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Figure 5. DHEAS for male and female subjects before and after a 20-minute bout of treadmill exercise at an 
intensity of 70% of age predicted maximal heart rate. 
*Significantly different (p=0.047) from female 
4.1.3 DHEAS change and age 
Results from the correlation analysis revealed a non-significant (p=0.097) negative correlation 
(r=-0.33) between change in DHEAS in response to 20 minutes of treadmill exercise at 70% of 
age predicted heart rate maximum and age. 
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4.2 PERCEPTIONS OF GLOBAL WELL-BEING AS MEASURED BY A 7 POINT 
LIKERT SCALE 
A seven point Likert scale (Appendix G) was used to assess perceptions of global well-being 
before and after exercise.  Reports of well-being significantly (p<0.05) increased from a pre-
exercise score of 4.4 + 1.3 to 5.2 + 0.9 post-exercise.  Figure 6 depicts perception scores before 
and after the exercise session. 
 
 
Figure 6.  Perceptions of global well-being scores before and after 20 minutes of treadmill exercise at an intensity of 
70% of age predicated maximal heart rate. 
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 Figure 7 depicts individual changes in perceptions of global well-being as a result of 
exercise compared to pre-exercise perceptions.  Fifteen subjects reported an improvement in 
well-being and ten subjects reported no change.  The subject with the highest pre-test well-being 
score (subject #13) reported normalization in well-being status.  This figure reveals a trend of 
greater improvement in perceptions of well-being in subjects who reported low (<4) pre-exercise 
perceptions of well-being. 
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Figure 7 Individual change in perceptions of global well-being post-exercise compared to pre-exercise scores. 
Note: Numbers correspond to individual subjects 
4.2.1 Perceptions of global well-being and age 
Results from the correlation analysis revealed a non-significant (p=0.43) negative correlation 
(r=-0.14) between change in perceptions of global well-being following exercise and age.   
4.2.2 Perceptions of global well-being and gender 
No significant difference was found between genders in the change of perceptions of global well-
being following exercise (p=0.50).  Prior to exercise, males had a Likert Score of 4.7+1.1 on the 
7-point scale.  This increased to 5.3+0.8 after the exercise bout.  Females reported a baseline 
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Likert score of 4.2+1.5.  This increased to 5.1+1.2 after undergoing the exercise protocol.  The 
results are presented in Figure 8. 
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Figure 8.  Scores in male and female global well-being before and after a 20-minute bout of treadmill exercise at a 
intensity of 70% of age predicted maximal heart rate. 
4.3   RELATION BETWEEN CHANGES IN LIKERT SCORES AND DHEAS  
As previously discussed, there was a significant improvement in perceptions of global well-being 
after 20 minutes of aerobic exercise.  In addition, DHEAS scores significantly increased after 
subjects completed the exercise protocol.  However, correlation analysis revealed a non-
significant (p=0.38) relation (r=0.18) between these variables.   
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5.0  CHAPTER 5 
The primary purpose of this study was to examine the effect of a 20 minute aerobic exercise bout 
performed at an intensity equal to 70% of age predicted maximal heart rate on DHEAS in 
patients diagnosed with bipolar disorder.  In addition, the effect of the exercise session on 
perceptions of global well-being was examined.  These findings are discussed below. 
5.1 DHEAS CHANGE WITH EXERCISE 
Previous studies have shown an increase in DHEA, and its sulfate ester DHEAS, in healthy 
subjects after performance of an aerobic exercise bout (Baker 1982; Cumming and Rebar 1983; 
Keizer 1987; Johnson et. al 1997).  To date, this is the first study to document a similar outcome 
in clinically diagnosed bipolar subjects, as results indicate a significant increase in DHEAS after 
a 20-minute, moderately intense exercise session in this population.   
Although a significant increase in DHEAS was found following exercise, it is important 
to note that not all subjects responded with an increase in DHEAS post-exercise.  In this study, 
DHEAS decreased in response to exercise in equal amounts of men (n=4) and women (n=4).  
Three of the four women that produced a decline in DHEAS were between the ages of 42-44 
years and one was 20 years old.  The male subjects in whom a decrease in DHEAS was 
observed, ranged in age from 45-61 years.   
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It is noteworthy that 3 of the 8 subjects who had a decrease in DHEAS indicated the 
existence of thyroid disease on their medical clearance form.  In contrast, only one subject with 
self-reported thyroid disorder had an increase in DHEAS.  Ravaglia et al. (2002) found a 
significant association between low DHEAS levels and decreased thyroid function, so there is 
potential for thyroid disorders to adversely effect DHEAS production. It is also important to note 
that the lone subject who began his exercise bout as “excessively happy or manic” had both a 
decrease in DHEAS and a normalization in perceptions of well-being.   
Past research has shown that DHEAS decreases in healthy individuals with age (Chiu 
1999), increases in response to exercise (Baker 1982, Keizer 1987, Johnson 1997) and is 
significantly higher in age-matched men compared to women (Perrini et. al 2005, Mazat et al, 
2001).   The present study revealed similar results when comparing DHEAS responses in men 
and women.  Men had significantly higher levels of DHEAS pre and post exercise when 
compared to women.  However, the increase in DHEAS as a result of the exercise session was 
similar between women and men.  
The Bland-Altman plot (Figure 4) of baseline DHEAS levels compared with individual 
DHEAS changes suggests that individual’s with high mean levels of DHEAS (i.e.>200 ug/dl) 
tend to have a greater magnitude of DHEAS response with exercise.   
5.2 CHANGES IN PERCEPTIONS OF GLOBAL WELL-BEING WITH EXERCISE 
The positive effect of exercise on the mood of depressed individuals has been well documented 
(Greist et al. 1979, Pert et al. 1979, Morgan et al. 1988, North et al. 1990,).  The present study 
showed similar improvements in perceptions of global well-being following exercise.  
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Of the 26 subjects, 10 reported no change in perceptions of well-being after exercise.  
Fourteen of the subjects reported that exercise improved global well-being by one to two points 
on the 7-point scale and one subject reported improvement of 3 points.  In contrast, one subject 
reported a decrease in global well-being after exercise.  This single subject reported that his well-
being changed from between moderately happy (6) and excessively happy or manic (7) to mildly 
happy (5).  This subject was one of the eight participants whose DHEAS decreased after the 
exercise bout.  While a decline in DHEAS cannot be proven as a cause for mediation of mania, it 
may become a useful focal point of future investigations.  
5.3 RELATION BETWEEN LIKERT SCORE AND DHEAS CHANGE 
The present study produced results similar to previous research, which suggests that acute 
exercise increases serum DHEAS levels as well as improves depressive symptoms.  It is 
interesting to note that the subjects in the present study who demonstrated the greatest 
improvement in perceptions of global well-being were not the subjects that produced the greatest 
increase in DHEAS.  Correlation analysis revealed a non-significant (p=0.38) relation (r=0.18) 
between changes in DHEAS and perceptions of global well-being.  Therefore, although DHEAS 
did increase significantly with exercise, it did not appear to be solely responsible for 
improvements in perceptions of well-being. 
Imbalances in HPA axis functioning have been linked to depression.  It is well 
established that depressed patients tend to have higher baseline basal cortisol levels (Akil et al., 
1993; Lesch et al., 1988).  Observations of abnormal cortisol levels in patients with depression 
were first noted as early as the late 1950’s (Michael et al., 1963).  These observations have been 
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consistently replicated (Webster et al., 2000; Wolkowitz 1994, Lauc et al., 2004).  Subsequent 
studies have shown that HPA hyperactivity occurs in sufferers of several mood disorders.  
Hypersecretion of Corticotropin-releasing hormone (CRH) causing hypercortisolemia may be a 
result of impaired feedback mechanisms.  While prolonged increases in cortisol levels could lead 
to changes in mood, a causal relationship has not firmly been established.  Elevation of cortisol 
through a prolonged stress response is only one factor that may be related to the mood changes 
associated with depression. 
Depression is generally marked by hyperactivity of the HPA axis and exercise training 
may lead to an attenuation of the axis response to stress.  Many neurotransmitters, neuropeptides, 
and hormones have been linked to the acute psychobiological response to stress and the long-
term psychiatric outcome.  The roles of these neurotransmitters, neuropeptides, and hormones 
have been shown to be altered by stress and have important functional interactions.  They 
mediate neural circuits relevant to regulation of reward, fear conditioning, and social behavior.  
(Holsboer 1995, 2000) 
Cortisol, Dehydroepiandrosterone, CRH, the locus coeruleus-norepinephrine system, 
neuropeptide Y, galanin, dopamine, serotonin, benzodiazepine receptors, gonadal steroids and 
estrogen are all implicated as being contributors, alone or through interaction, to resilience to 
stress.  The hypothesis of the allostatic load theory states that the cumulative effect of modest 
dysregulation in multiple systems could be substantial, even if independently they have minimal 
impact on health.  (Charney, 2004) 
Browne, et al (1992) suggested that DHEA and/or DHEAS may act as antagonists of 
glucocorticoids.  Healthy persons with high ACTH-releasing hormone and cortisol responses to 
exercise exhibit higher baseline levels of DHEA and DHEAS, which may enhance the 
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hypothalamic-pituitary-adrenal response to exercise (Deuster 2005).   Furthermore, the allostatic 
load theory hypothesizes that when cortisol and DHEA/DHEAS work together in harmony, the 
organism optimally adapts to stress.  When the body is unable to maintain a normal cortisol to 
DHEAS ratio, a state of maladaptation to stress may ensue.  Therefore, it is possible that the ratio 
of cortisol to DHEAS is of utmost importance; not solely the level of DHEAS.  Further research 
in this area is necessary to further understand this mechanism.   
5.4 IMPLICATIONS 
This results of the present study suggest the following: 1) moderately intense aerobic exercise is 
beneficial in improving the perceptions of well-being in bipolar individuals, 2) DHEAS increases 
as a result of participating in 20 minutes of moderately intense exercise, and 3) other unmeasured 
factors in addition to an increase in DHEAS may be responsible for improvements in perceptions 
of global well-being that result from exercise.   
Prescribing aerobic exercise for bipolar subjects may help these individuals better cope 
with Bipolar Disorder.  Exercise is inexpensive, easily prescribed and a safe adjunct to other 
treatment modalities.  Exercise is helpful in prevention of chronic physical diseases and has a 
positive impact on cardiovascular disease risk factors.  In addition, thyroid disorders have been 
shown to adversely affect DHEAS levels.  Alterations of DHEAS levels have been reported in 
hypothyroidism (Ravaglia et al., 2002).  While the majority of thyroid-disordered subjects in the 
present study did not show an increase in DHEAS in response to exercise, they did report 
improvement in perceptions of global well-being.  Therefore, bipolar patients, regardless of 
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thyroid condition, derive a benefit from exercise in combination with their regular 
pharmaceutical and therapeutic treatment.   
As indicated in Figure 7, there appears to be a trend in perceptions of global well-being 
such that subjects who reported lower scores prior to exercise had the greatest improvements in 
perceptions of well-being.  In addition the sole subject who presented as hypo-manic (Likert 
score of 6.5) reported a “neutralization” of well-being post-exercise.  The majority of subjects 
who began the exercise bout in a “normal” well-being state reported little change in well-being 
scores post-exercise.  These results indicate that exercise could possibly help bipolar suffers 
moderate well-being and further research in this area should be conducted.   
5.5 LIMITATIONS 
There are several limitations in this study.  First, all of the subjects in this study were medicated 
with various combinations of prescription medications.  Secondly, we used a novel 7-point 
Likert Scale to measure perceptions of global well-being.  Third, it is possible there was a 
training response of DHEAS in some subjects.  Finally, the possibility of an anticipatory effect 
could have resulted from testing subjects who had knowledge of a desired result (improved 
perceptions of well-being from exercise).     
5.5.1 Medication as a Confounder 
Bipolar subjects typically are prescribed multiple combinations of medications to control their 
disorder.  Limited research exists on the impact of specific medications and DHEAS levels.  
However, significant and strong inverse associations between DHEAS and the number but not 
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with any specific type of medications have been observed.  (Ravaglia et al., 2002)  Therefore, 
medications could be a confounding factor in the present research.  Since the number of 
medications may influence baseline DHEAS levels, it follows that medications could have an 
impact on the amount of DHEAS change in response to exercise.  While the present study found 
that DHEAS increases with exercise, the impact of medication on the response is unknown.     
 
5.5.2 7-point Likert Scale 
A 7-point Likert Scale, developed specifically for this study was used to analyze perceptions of 
global well-being.  Previous studies have utilized the Profile of Mood State Questionnaire 
(POMS) or Becks Depression Inventory (BDI) to assess levels of depression or mood status.  
Both of these questionnaires ask subjects to report feelings inclusive of the past week.  The 
POMS is 65 questions in length and the BDI contains 21 questions.  As such, these tools were 
not ideal instruments to assess current perceptions of well-being in the present investigation.  
The 7-point Likert scale proved easy to use and simple in design and has face validity.  
Therefore, it may be a reasonable measure of perceptions of well-being.  Validation of this scale 
could be a focal point of future research.   
5.5.3 Training history and fitness level 
This study did not control for training history or fitness level.  It is possible that the DHEAS 
response to acute aerobic exercise may be influenced by these factors.  Tissandier et al., (2001) 
suggested that DHEAS concentrations are higher among trained individuals when compared to 
untrained controls.  Although the experimental paradigm employed by Tissandier et al. did not 
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involve acute exercise, many other studies have demonstrated an increase in DHEAS with acute 
exercise (Cumming et al., 1986; Diamond et al., 1989; Velardo et al., 1991). Two studies 
conducted in small samples of middle-aged and older subjects (n=42, n=42) reported no changes 
in resting DHEAS with 6 months of training.  (Hakkinen et al., 2000; Hersey et al., 1994)  In 
addition, Riechman et al., (2004) reported increased plasma DHEAS levels following acute 
resistance training in healthy, young subjects.  However the magnitude of the acute changes in 
DHEAS decreased following 10 weeks of resistance exercise training.  In the current study, 
individual training history and fitness status were not documented.  Future investigations should 
examine the impact of these variables on the DHEAS response to aerobic exercise. 
5.5.4 Potential for Hawthorne Effect 
Another possible limitation to this study includes the Hawthorne effect of testing human 
subjects.  The research team did not inform subjects of any desired outcome, however many of 
the subjects expressed knowledge of the potential for exercise to improve mood.  It is possible 
that subjects wanted to report a “normal” response to exercise and they may have reported an 
improvement in well-being on the 7-point Likert scale.  Knowledge of the expected response 
may have lead to faulty perceptions of well-being reports as subjects may have indicated an 
improvement without properly assessing their true mood state.  
5.6 FUTURE DIRECTIONS 
The results of this study demonstrated that treadmill walking at an intensity of 70% of age 
predicted heart rate max for 20 minutes produced a significant increase in DHEAS and 
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improvement in perceptions of global well-being.  Possible future directions of research are 
described below. 
5.6.1 Causes of changes in perceptions of global well-being  
The rise in DHEAS does not appear to be the sole cause of improvement in perceptions of global 
well-being following an acute bout of exercise.  Therefore, future studies should explore 
alternative mechanisms for the improvement in perceptions of well-being.  Many 
neurotransmitters, neuropeptides, and hormones have been linked to the acute psychobiological 
response to stress and long-term psychiatric outcome.  The roles of these neurotransmitters, 
neuropeptides, and hormones have been shown to be altered by stress and have important 
functional interactions.  They mediate neural circuits relevant to regulation of reward, fear 
conditioning, and social behavior.  Cortisol, Dehydroepiandrosterone, CRH, the locus coeruleus-
norepinephrine system, neuropeptide Y, galanin, dopamine, serotonin, benzodiazepine receptors, 
gonadal steroids and estrogen have been implicated as being contributors, alone or through 
interaction, to resilience to stress.  (Charney, 2004) The hypothesis of allostatic load also states 
that the cumulative effect of modest dysregulation in multiple systems could be substantial, even 
if independently they have minimal impact on health (McEwen 2002).  Due to the potential for 
DHEAS to mediate the effect of elevated cortisol levels, the cortisol/DHEAS ratio in exercising 
bipolar subjects needs to be explored as well as other possible combinations of hormones. 
5.6.2 Effect of exercise DHEAS levels in mania  
The single participant that indicated a hypomanic state of well-being prior to exercise reported 
normalization in well-being and a reduction in DHEAS level after the exercise session.  Whether 
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mania can be affected by exercise via a reduction in DHEAS and/or other hormonal regulation 
should be investigated.   
5.6.3 Effect of various exercise modes, durations, intensities and fitness levels 
In 2004, Tremblay studied the effects of acute bouts of aerobic and resistance exercise on DHEA 
in trained and sedentary individuals.  This study found that DHEA increased following both 
resistance and aerobic exercise.  However, increases in DHEA were greater after resistance 
exercise than aerobic exercise.  The exercise that elicited the greatest levels of DHEA elevation 
proved to be resistance exercise in resistance-trained subjects.  Tremblay et al., also 
demonstrated a significant increase in cortisol only after resistance exercise.  Therefore, DHEAS 
in response to various modes of exercise and in conjunction with other hormones should be 
further explored.   
Tramblay et al. (2005) found the duration of exercise to have an impact on DHEAS 
levels.  DHEAS increased in a dose-response manner with the greatest increases observed in 
response to a 120 minute run compared to 40 and 80 minute runs at an intensity of 55% of VO2 
max.  In addition the relation between DHEAS and VO2 max suggests that higher intensity 
exercise may elicit a greater increase in DHEAS (Bonnefoy et al., 1998).  Therefore, exercise 
duration and intensity may have independent effects on the hormonal responses to aerobic 
exercise.   
Changes in perceptions of well-being in response to various modes and intensities of 
exercise in bipolar subjects could also be important information to explore in future studies.  The 
present study was limited to 20 minutes of aerobic exercise.  It is possible that longer or shorter 
bouts of exercise could produce different DHEAS and perception responses.  Identification of a 
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“threshold” or optimal volume and intensity of exercise to improve perceptions of well-being 
and hormonal response needs to be defined.   
This study did not control for training status or fitness level in subjects.  Current literature 
provides mixed results regarding the effects of training on DHEAS and change in DHEAS in 
response to an acute bout of activity.  Future studies should examine the impact of fitness level 
and training response on DHEAS and perceptions of well-being.   
While not a hypothesis or outcome of this study, issues related to exercise intensity and 
duration are frequently a concern especially when developing experimental paradigms involving 
unique clinical populations.  In this study, the protocol involved treadmill walking at an intensity 
of 70% of age predicted maximal heart rate for 20 minutes.  All subjects were able to complete 
this protocol safely; therefore, future investigations could utilize this, or perhaps an even more 
vigorous exercise protocol.    
5.6.4 Control for medications 
While limited research exists on DHEAS levels and use of specific medications, significant and 
strong inverse associations of DHEAS with the number but not with any specific type of 
medications have been observed.  (Ravaglia et al., 2002)  Therefore, medications could be a 
confounding factor in this research and effects of medications on DHEAS need to be further 
explored.   
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5.7 CONCLUSIONS 
The present study has shown that an acute bout of treadmill exercise at an intensity of 70% of age 
predicated maximal heart rate significantly increased serum DHEAS levels in clinically diagnosed 
bipolar subjects.  Bipolar subjects reported an improvement in perceptions of global well-being 
after participating in this 20-minute aerobic exercise protocol.  The increase in DHEAS may 
contribute to improvements in perceptions of well-being; however, this hormonal response may be 
only one part of the complex etiology associated with bipolar disorder.   Regardless of the 
etiology, the improvement in perceptions of well-being seen with exercise in this population is an 
important finding.  Ultimately, it is hoped that the incorporation of an exercise program as part of 
the treatment for bipolar patients becomes more widely utilized.  Exercise, unlike many 
medications, has no negative side effects and a wide range of positive outcomes when prescribed 
and applied correctly.  
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APPENDIX A 
PRESCREENING SCRIPT 
“Hello, my name is Anne Hays from the University of Pittsburgh.  Dr. Friedman of the Bipolar 
Disorder Clinic of Pennsylvania and I are working on a study involving exercise and brain 
chemistry.  Is now an OK time to discuss this project with you?” 
 
“The test is a simple one that would take about an hour to complete and for your time you would 
receive $25.  This is a one-time visit and you would not be obligated for any other time on this 
study.  All information will remain confidential.” 
 
(Conformation of the following)    
 
1.  You are currently clinically diagnosed with bipolar disorder, correct? 
2.  You are currently in outpatient status at the Bipolar Disorder Clinic of Pennsylvania, correct? 
3. Females: Are you pregnant?  If not, do you currently use birth control so that you are 
confident that you will not be able to become pregnant with in the next two months? 
4.  Have you ever had a heart attack? 
5.  Are you currently on beta-blocker medication? 
6.  Are you diabetic? 
7.  Are you able to perform moderate exercise for at least 30 minutes? 
 
If question 1 or 2 are no or 3-7 yes: 
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 “Unfortunately there is a problem.  With our protocol, we require that _________.(you are not 
diabetic, for example).  I thank you for your time.  Have a great day.” 
 
If question 1 and 2 are yes, and 3-7 no, agree to continue: 
 
 “Great, your information qualifies you for the study.  Is this something you would be interested 
in participating in?  If you decide you’d like to take part in this study, I will collect your primary 
care doctor’s contact information.  I will obtain a medical clearance from him/her that states 
he/she is aware you will be participating in an exercise study.  This will be done to ensure your 
safety in the study.  After your doctor signs that it is safe for you to exercise, you can appear for 
the actual testing session.  I will take care of all the paper work involved with that.” 
 
“Would you like to participate in this study?” 
(If yes, continue.) 
 
“Please answer the following questions.”  (Read PAR-Q or have subject fill out PAR-Q) 
 
“Please fill out this medical history questionnaire which helps me know that you are safe to 
exercise.” (Give Medical History Questionnaire) 
 
“Everything looks good.  Let’s schedule a time for your exercise test that is at least 3 days from 
now.  That will give me time to send the medical clearance form to your primary care physician.  
In addition, we must schedule your test for a time when you think you will have been awake for 
at least 3 hours before the test.” 
 
(Schedule test date and time) 
 
“Please remember to maintain your regular schedule of eating and medication the day of the 
exercise test.  Please do not exercise the day prior to or the day of your scheduled exercise test.  
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Do not consume alcoholic beverages the day prior to or the day of your exam.  Remember to 
wear comfortable exercise clothing to the test and to drink plenty of water the day of the exam.” 
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APPENDIX B 
PHYSICAL ACTIVITY READINESS QUESTIONNAIRE 
PAR – Q 
 
Date:   ______________ 
Subject number: ______________ 
 
 
 
Yes / No 
__________ 1.  Has your doctor ever said you have a heart condition and that you 
should only do physical activity recommended by a doctor?   
 
__________ 2.  Do you feel pain in your chest when you do physical activity? 
 
__________ 3.  In the past month, have you had chest pain when you were not doing 
physical activity? 
 
__________ 4.  Do you lose your balance because of dizziness or do you ever lose 
consciousness? 
 
__________ 5.  Do you have a bone or joint problem (for example back, knee or hip) 
that could be made worse by a change in your physical activity? 
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 __________ 6.  Is your doctor currently prescribing drugs (for example, water pills) for 
your blood pressure or heart condition?   
 
__________ 7.  Do you know of any other reasons why you should not participate in 
physical activity?   
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APPENDIX C 
MEDICAL HISTORY QUESTIONNAIRE 
 
Demographic Information 
 
 
Last Name    First Name            Middle Initial 
 
 
Age     Gender   Home Phone 
 
 
Address    City, State   Zip Code 
 
 
Work Phone       E-Mail Address 
 
 
Emergency Contact      Phone Number 
 
Primary Therapist   Phone Number  E-Mail Address 
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Primary Care Physician  Phone Number    Fax Number 
 
List all medications you are currently taking (include dosage): 
______________________________________________________________________________
______________________________________________________________________________ 
 
  
Risk Factors: 
1.  Have any of your parents, brothers, sisters had a heart attack, bypass  
     surgery angioplasty, or sudden death prior to the age of 55 (male relatives)  
     or 65 (female relatives)?       YES NO 
 
2.  Have you smoked cigarettes in the past 6 months?   YES NO 
 
3.  What is your usual blood pressure (>140/90)?  __________ 
     Do you take blood pressure medication?    YES NO 
      
4.  What is your LDL cholesterol?  If you don’t know your LDL, what is   
     your total cholesterol?  What is your HDL cholesterol? 
     (Either LDL >130 (use total cholesterol >200 if LDL is not known) OR HDL <40) 
       
      LDL________  TC________ HDL________ 
 
5.  What is your fasting glucose (>110)? ________ 
     
6.  What is your height and weight (BMI >30)?  
 
     Height________ Weight________  BMI________ 
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7.  Do you get at least 30 minutes of moderate physical activity most days 
     of the week?         
YES NO 
 
Signs and Symptoms: 
1.  Do you have pain or discomfort in your chest or surrounding areas?  
YES NO 
 
2.  Do you ever feel faint or dizzy (other than sitting up rapidly)?  
YES     NO 
 
3.  Do you find it difficult to breathe when you are lying down or sleeping? 
YES NO 
 
4.  Do your ankles ever become swollen (other than after long periods 
     of standing or sitting)?       
YES NO 
 
5.  Do you ever have heart palpitations, or an unusual period of rapid 
     heart rate?        
YES NO 
 
6.  Has a physician ever said you had a heart murmur? (Has he/she said 
     it is OK, and safe for you to exercise?)      
YES NO 
 
7.  Do you feel unusually fatigued or find it difficult to breathe with usual 
     activities?         
YES NO 
 
8.  Do you ever experience cramp-like pain in your calves?    
 66 
YES NO 
 
Other: 
1.  When was the last time you had a physical examination? 
_____________________ 
 
2.  Do you have any of the following diseases:  heart disease, peripheral vascular 
disease, cerebrovascular disease, chronic obstructive pulmonary disease 
(emphysema or chronic bronchitis), asthma, interstitial lung disease, cystic fibrosis, 
diabetes mellitus, thyroid disorders, disease, or liver disease?    
  YES NO 
 
If you answered “yes” to the above question list the 
condition(s)_____________________________________________________________
________________________________________________________________________ 
 
3.  Do you have any bone or joint problems, such as arthritis or a past injury that 
might get worse with exercise?        
YES NO 
 
If you answered “yes” to the above question list the 
condition(s)_____________________________________________________________
_______________________________________________________________________ 
 
4.  Have you ever been hospitalized or undergone surgery?   
YES NO 
 
If you answered “yes” to the above question describe 
conditions_______________________________________________________________
________________________________________________________________________ 
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5.  Are you pregnant or lactating?       
YES NO 
 
6.  Do you have any other problem that might make it difficult for you to  
     exercise?         
YES NO 
 
If you answered “yes” to the above question list the 
condition(s)___________________________________________________________________
______________________________________________________________________________ 
 
 
****************************************************************************** 
To be completed by the interviewer: 
 
Interpretation: 
_____ Low Risk:  young and no more than one risk factor 
_____ Moderate Risk:  older, or 2 or more risk factors 
_____ High Risk:  known disease or at least one major sign or symptom 
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APPENDIX D 
MEDICAL CLEARANCE FORM 
TO:  __________________________________ 
 
Fax #: _________________________________ 
 
FROM:  Anne Hays, MS  
Fax #: (412) 648-7092 
Phone: (412) 478-1190                      
 
 
Dear Dr. ____________________________, 
 
Your patient _______________________________ has agreed to be in a research study 
investigating the effects of an acute bout of aerobic exercise on Dehydroepiandostrone-sulfate 
(DHEAS) in bipolar subjects.  With your approval, your patient will undergo a 5-minute light 
walk on a motor driven treadmill.  Next, a 20-minute walk/run sequence that elicits a 70% of age 
predicted heart rate maximal response would occur.  After 20 minutes of walking/running at this 
pace, your patient will cool down for 5 minutes to allow for heart rate and blood pressure to 
normalize.   
 
Approximately 9 ml of blood will be drawn from an anticubital vein by a certified 
phlebotomist both before and after the exercise session to analyze DHEA.   
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Please sign the statement below and fax back to: (412) 648-7092 at your earliest 
convenience.  Should you have any questions or concerns regarding this study or should you 
want more information, feel free to contact me at (412) 478-1190 at any time. 
 
Thanks, in advance, for your cooperation. 
 
 
In Health, 
 
Anne E. Hays 
Primary Investigator 
U of Pittsburgh School of Education / WPIC 
 
______________________________________________________________________________ 
 
My patient __________________________, is safe to exercise at a submaximal (70% of age 
predicted heart rate maximum) aerobic exercise rate for 20 minutes, and has my encouragement 
to do so.   
                                                  
 
 
Primary Care Physician Signature:__________________________________________________                         
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APPENDIX E 
INFORMED CONSENT 
CONSENT TO PARTICIPATE AS A SUBJECT IN A CLINICAL RESEARCH STUDY 
 
TITLE: Effects of an Acute Bout of Aerobic Exercise on Dehydroepiandosterone Levels in 
Clinically Diagnosed Bipolar Subjects. 
 
PRINCIPAL INVESTIGATOR:   
Anne Hays, Ph.D. Candidate, Exercise Physiology 
140 Trees Hall 
University of Pittsburgh 
Pittsburgh, PA 15213 
412) 478-1190  
 
CO-INVESTIGATORS:       
 Edward S. Friedman, M.D.    Fred Goss, Ph.D. 
Associate Professor of Psychiatry   Professor of Exercise Physiology 
Western Psychiatric Institute and Clinic  113 Trees Hall  
3811 O’Hara Street, Room 848 BT   University of Pittsburgh 
Pittsburgh, PA 15213     Pittsburgh, PA 15213 
 (412) 246-6111     (412) 648-8259 
 
     
SOURCE OF SUPPORT:  School of Education Grant, University of Pittsburgh 
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INTRODUCTION: 
 
You are being asked to participate in a research study that is attempting to find out if 
aerobic exercise is helpful for people with bipolar disorder.  Before agreeing to participate in this 
research study, it is important that you read and understand this form.  It describes the purpose, 
procedures, benefits, risks, discomforts, and precautions of the study.   
 
Why is this research being done? 
 
We are also particularly interested in examining if Dehydroepiandrosterone (DHEA), a 
hormone in the human body that may be associated with the way the human brain works, may 
help relieve symptoms of depression.   We will determine the effect of an aerobic exercise 
session on this hormone in the blood stream of people with bipolar disorder.  DHEA is present in 
every human body, however, it may be lower in people with bipolar disorder and exercise may 
increase it, helping relieve symptoms of the disease.   
There are no medications used in this trial.  Exercise, unlike many medications, has no 
negative side effects and a wide range of positive outcomes when prescribed and applied 
correctly.  There is a great deal of evidence linking physical activity to a decrease in depressive 
symptoms. There is a need for reliable evidence about how aerobic exercise can help reduce the 
need for medical and psychiatric intervention for bipolar disorder.  To date much of the research 
into bipolar disorder has focused on the immediate management of symptoms of mania and 
depression rather than on the management of illness thru an exercise program. 
 
Who is being asked to take part in this research study? 
 
You have been asked to take part in this study because you have been diagnosed with 
bipolar disorder and because your study psychiatrist feels you will benefit from participation in 
this research exercise program. Your study psychiatrist will continue providing your care and 
will work closely with the investigators of this study. 
We expect to enroll 28 male and female subjects (age range) in this study at Western 
Psychiatric Institute and Clinic and those participants in the Bipolar Disorders Center for 
Pennsylvanians.  Individuals of all ethnic backgrounds and ages will be included so that we may 
learn more about how an exercise program along with bipolar treatment may help bipolar 
patients regardless of ethnicity or age.   
 
What procedures will be performed for research purposes? 
 
Screening Procedure 
After you have signed the informed consent, you will be screened for eligibility by a 
review of the inclusion and exclusion criteria via phone.  You will also be asked several 
questions regarding your current health to insure your safety in this study.  Your primary care 
doctor will be required to sign a clearance form, which states he/she is aware of your 
participation in an exercise study and he/she believes you are safe to do so.  There is no cost to 
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you for this procedure.  The primary investigator in the study will ask you for your primary care 
physician’s contact information and proceed with gathering the necessary signatures.   
You must be free of diagnosed heart, lung or blood pressure disease, able to perform 
moderate aerobic exercise for a minimum of 20 minutes. Your Primary Care Physician (PCP) 
will need to sign a medical clearance to participate in this aerobic exercise research portion. 
Additionally, you will be required to have had a recent (within three months of entering this 
study) electrocardiogram(ECG) to assess your heart health. This ECG is simply a test that 
measures the electricity of your heart.  You will be asked via phone to complete a questionnaire 
called the Physical Activity Readiness Questionnaire (PAR-Q).  It asks you questions about your 
current activity level.  You will also be asked questions regarding your medical history (Medical 
History Questionnaire) to ensure your safety in this study.  They are simple questions about your 
current health status. 
 If you agree to participate in this study, you will continue to see the same psychiatrist 
you are already seeing in the BDCP study.  You will maintain your regular schedule of eating 
and taking medication. You will not exercise or consume any alcoholic beverages the day prior 
to or the day of the exercise exam. The day of the exam you will wear comfortable exercise 
clothing and drink plenty of water.  The appointment will be scheduled three hours after you 
normally awaken.  The exam will take approximately one hour and you are only required to 
appear one time.   
 
Experimental Procedures:  
Before the testing begins you will complete the Likert 7 point scale for perceptions of 
global well-being.  This scale simply asks you to rate your mood at the time of testing.   
 
1. You will have your blood drawn by a trained technician at the Human Energy 
Laboratory.  They will draw a small sample of your blood from a vein in your arm (about 3 
tablespoons (tbsp) and prepare it to be sent to Montifour Hospital for analysis.   The primary 
investigator of this research project will be in control of all blood samples.  Each sample will be 
de-identified and replaced with a specific study code number.  The informational sheet that will 
be the only correlate between subject name and subject study number, will be kept in a locked 
room separate from other study materials.  All blood samples must be acquired prior to 
submission to an analysis laboratory at Montifour Hospital.  Therefore, all samples will be kept 
indefinitely.  Once all samples have been analyzed, they will be discarded in appropriate 
biohazard containers.  No samples will be used in future studies or given to other investigators. 
2. You will have your height, weight, muscle mass and body measurements 
measured by a qualified exercise physiologist in the Human Energy Laboratory.   
3.   You will wear a Polar Heart Rate Monitor (Model number A3) on your chest that 
is affixed with an elastic band to keep it secured.   
4. You will be asked to perform a two-minute warm-up on a Trackmaster treadmill.  
You will be monitored by heart rate every 15 seconds and recorded every minute. Your blood 
pressure will be monitored every 5 minutes.   
5. The warm-up will immediately be followed by increased difficulty based on your 
heart rate response to the activity.  Once your heart rate has increased to a moderate intensity, 
your activity will be maintained at that level for a minimum of twenty minutes. Your heart rate 
will be monitored every minute and your blood pressure recorded every five minutes.   
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6. After twenty minutes of exercise, you will be returned to resting heart rate and 
blood pressure using standard cool down procedures.  You will be given water and/or juice. This 
testing will occur in the Human Energy Research Laboratory at the University of Pittsburgh and 
will take approximately 1 – 1½ hours. 
7. After a five-minute cool down a second blood draw, identical to the first, (3 tbsp) 
will be performed and will again be analyzed. 
8.   After completion of the exam, the investigator will review the exercise test results 
with you and answer any questions you may have.  You will then complete the Likert 7 point 
scale for mood again.   
 
 
What are the possible risks, side effects, and discomforts of this research study?  
 
As with any research study, there may be adverse events or side effects that are currently 
unknown and it is possible that certain of these unknown risks could be permanent, serious or 
life threatening.  Once you have enrolled in this study, your clinician’s decisions are based solely 
on his or her best clinical judgment, and are not influenced by or guided by the research protocol 
in any way.   
Risk of Venipuncture: There does exist the possibility of certain undesirable outcomes 
with a standard blood draw.  It is common for bruising and/or inflammation to occur at the site of 
the draw (25-30% of subjects will experience this).  The site may also become tender, and sore. 
Rarely the site may become infected or you may feel dizzy or faint (5% risk). All precautions 
will be taken to ensure the site will not become infected, but realize infection of the site is a risk 
(5%).    
Risk of Exercise Testing: You will perform an exercise test on a motor driven treadmill.  
The exercise intensity will begin at a low level and will be stopped any anytime because of signs 
of fatigue or inappropriate changes in your heart rate or blood pressure (10% risk).  You may 
stop when you wish because of feelings of fatigue or any other discomfort.  If you experience 
those feelings or any other discomfort, you must agree to inform the testing personnel involved. 
There exists the possibility of certain side effects occurring during this test.  This includes 
abnormal blood pressure, panting, irregular, fast or slow heart rhythm, and in rare instances, 
heart attack, stroke or death.  To minimize risks associated with aerobic exercise, you will be 
asked to complete a Physical Activity Readiness Questionnaire that asks question about your 
current health status.  In addition, you will be asked to complete a medical history form, which 
helps the investigators understand your risk of adverse effect from exercise. Incidence of heart 
attack or stroke in individuals cleared in this manner is rare (less than 1%).  Every effort will be 
made to minimize your risk and should abnormal responses be observed, the test will be 
terminated. 
In the event of an abnormal response to exercise, and test termination, emergency 
equipment and trained personnel are available in the Human Energy Research Laboratory to deal 
with any unusual situation. Additionally, security and emergency equipment are within the 
building.  
If you have any current health status or previous experiences of unusual feelings with any 
physical effort that may affect the safety and value of this exercise test, you must notify the 
investigator.  It is important that you report any feelings that your experience with effort during 
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the exercise test itself.  You need to acknowledge, agree and understand the importance of fully 
disclosing such information when requested during the test by testing staff.   
 
As with any experimental procedure, there may be adverse events or side effects that are 
currently unknown, and certain of these unknown risks could be permanent, severe, or life 
threatening. 
Previous studies on the effect of aerobic exercise at 70% of maximal effort, have not been 
done on pregnant women, therefore the risks on a fetus is unknown.  To avoid risk to a fetus, it is 
important that any female subject in this study remain impregnate until the exercise test date has 
been completed.  Avoiding sexual activity is the only certain way to avoid pregnancy, however if 
you choose to become sexually active, you should use an appropriate “double barrier” method of 
birth control (such as female use of a diaphragm, intrauterine device (IUD), or contraceptive 
sponge, in addition to male use of a condom) or the female should be using prescribed “birth 
control” pills, injections, or implants.  Such birth control methods should be used until your 
exercise test date has been completed.  If you choose to be sexually active during this study, you 
understand that even with the use of these birth control measures pregnancy could still result.  
The risks of undergoing aerobic exercise while pregnant include potential loss of pregnancy or 
possible birth defects. 
 
What are the possible benefits from taking part in this research study? 
 
There may be no benefit to you for participating in this trial.  The goal of this project is to 
demonstrate a physiological response that could begin to explain how if when you exercise, your 
mood becomes more stable.  This will help clinicians develop exercise as a prescription for 
bipolar disorder.  Data collected from this study may later help clinicians determine the best 
methods for maintenance treatment for patients with bipolar disorder.  In the future, other 
patients may benefit from your participation. 
 
What treatments or procedures are available if I decide not to take part in this research 
study? 
 
You may continue to receive care through your psychiatrist, and your quality of care will 
not be affected.   
 
If I agree to take part in this research study, will I be told of any new risks that may be 
found during the course of the study? 
 
You will be notified if any new information develops during the conduct of this research 
study, which may cause you to change your mind about continuing to participate. 
 
Who will be responsible for the compensation of illness or injury? 
 
The University of Pittsburgh investigators and their associates who provide services at 
the University of Pittsburgh Medical Center (UPMC) recognize the importance of your voluntary 
participation to their research studies.  These individuals and their staff will make reasonable 
efforts to minimize, control, and treat any injuries that may arise as a result of this research. 
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If you believe that you are injured as the result of the research procedure being 
performed, please immediately contact the Principal Investigator or one of the co-investigators 
listed on the coversheet of this form at (412) 246-6111.  Emergency medical procedures for 
injuries solely and directly relating to your participation in this research will be provided to you 
by hospitals of UPMC.  It is possible that UPMC may bill your insurance provider for the costs 
of this emergency care, but none of these costs will be charged directly to you.  If your research-
related injury requires medical care beyond this emergency procedure, you will be responsible 
for the costs of this follow-up care unless otherwise specifically stated below.  There is no plan 
for monetary payment for, or associated with, any injury that you suffer in relation to this 
research.  
You do not, however, waive any legal rights by signing this form. 
 
Will I or my insurance provider be charged for the costs of any procedures performed as 
part of this research study? 
 
No charge will be made to you or your health care provider for your participation in this 
exercise test. 
 
Will I be paid if I take part in this research study? 
 
You will be paid $25 after the completion of your individual test.   
 
Who will know about my participation in this research study? 
 
Any information about you obtained from or for this research study will be kept as 
confidential (private) as possible.   All records related to your involvement in this research study 
will be stored in a locked file cabinet.  Your identity on these records will be indicated by a study 
number rather than by your name, and the information linking these case numbers with your 
identity will be kept separate from the research records.  The confidentiality of your research 
records will be maintained in the same way that your medical records are kept confidential, 
according to Federal, State, and UPMC regulations.   You will not be identified by name in any 
publication of the research results unless you sign a separate form giving your permission 
(release). 
 
Will this research study involve the use or disclosure of my identifiable medical record 
information? 
 
This research study will involve the recording of current and/or future identifiable 
medical information from your hospital and/or other health care provider (e.g., physician office) 
records.  The information that will be recorded will be limited to information concerning your 
current and past psychiatric and medical history.  This information will be used for the purpose 
of determining your eligibility for this study. 
  
Who will have access to identifiable information related to my participation in this 
research study? 
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In addition to the investigators listed on the first page of this authorization (consent) form 
and their research staff, the following individuals will or may have access to identifiable 
information (which may include your identifiable medical record information) related to your 
participation in this research study:  Authorized representatives of the University of Pittsburgh 
Research Conduct and Compliance Office may review your identifiable research information 
(which may include your identifiable medical record information) for the purpose of monitoring 
the appropriate conduct of this research study.   In unusual cases, the investigators may be 
required to release identifiable information (which may include your identifiable medical record 
information) related to your participation in this research study in response to an order from a 
court of law.  If the investigators learn that you or someone with whom you are involved is in 
serious danger or potential harm, they will need to inform, as required by Pennsylvania law, the 
appropriate agencies.  
Authorized representatives of UPMC hospitals or other affiliated health care providers 
may have access to identifiable information (which may include your identifiable medical 
information related to your participation in this research study for the purpose of (1) fulfilling 
orders, made by investigators, for hospital and health care services (e.g., laboratory tests, 
diagnostic procedures) associated with research study participation; (2) addressing correct 
payment for tests and procedures ordered by the investigators; and/or (3) for internal hospital 
operations (i.e. quality assurance.) 
 
For how long will the investigators be permitted to use and disclose identifiable 
information related to my participation in this research study? 
 
The investigators may continue to use and disclose, for the purposes described above, 
identifiable information (which may include your identifiable medical record information) 
related to your participation in this research study.   Your research records will be destroyed as 
per University policy.  It is a University policy that all research records must be maintained for at 
least 5 years following study completion. 
May I have access to my medical record information that results from my participation in 
this research study? 
In accordance with UPMC Notices of Privacy Practices document that you have been 
provided, you are permitted access to information (including information resulting from your 
participation in this research study) contained within your medical records filed with your health 
care provider unless otherwise specifically stated below. 
 
Is my participation in this research study voluntary?  
 
Your participation in this research study, to include the use and disclosure of your 
identifiable information for the purposes described above, is completely voluntary. (Note, 
however, that if you do not provide your consent for the use and disclosure of your identifiable 
medical record information for the purposes described above, you will not be allowed, in 
general, to participate or continue to participate in the research study.)   You are free to deny any 
consent you so desire both now and at any time during the exercise test or the participation in 
this protocol. 
Whether or not you provide your consent for participation in this research study will have 
no affect on your current or future relationship with the University of Pittsburgh. Whether or not 
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you provide your consent for participation in this research study will have no effect on your 
current or future medical care at a UPMC hospital or affiliated health care provider or your 
current or future relationship with a health care insurance provider.   
 
Your doctor is interested both in your medical care and the conduct of this research study. 
Before agreeing to participate in this research study, or at any time during your study 
participation, you may discuss your care with another doctor who is not associated with this 
research study.  You are not under any obligation to participate in any research study offered by 
your doctor. 
 
May I withdraw, at a future date, my authorization (consent) for the use of my identifiable 
medical record information for the purpose of this research study? 
 
You may withdraw, at any time, your consent for participation in this research study, to 
include the use and disclosure of your identifiable medical record information for the purposes 
described above. (Note, however, if you withdraw your consent for the use and disclosure of 
your identifiable medical record information, you will also be withdrawn, in general, from 
further participation in this research study.)  Any identifiable medical record information 
recorded for, or resulting from, your participation in this research study prior to the date that you 
formally withdrew your authorization may continue to be used and disclosed by the investigators 
for the purposes described above.  You may withdraw consent due to any reason, such as an 
inability to comply with study procedures.  It is important to remember that any additional 
treatment you may require is an outcome for this study, and therefore is always an option for 
you.  
To formally withdraw your consent you should provide a written and dated notice of this 
decision to the principal investigator of this research study at the address listed on the first page 
of this form. 
Your decision to withdraw your consent for the research use and disclosure of your 
medical record information will have no effect on your current or future relationship with the 
University of Pittsburgh. Your decision to withdraw this consent will have no effect on your 
current or future medical care at a UPMC hospital or affiliated health care provider or your 
current or future relationship with a health care insurance provider.   
 
If I agree to participate in this research study, can I be removed from the study without my 
consent? 
 
You may be withdrawn from study participation if, by process of review, your completed 
Health History Questionnaire and Physical Activity Readiness Questionnaire deem participation 
unsafe for you.  If your primary care physician declines to sign a medical clearance for your 
participation, you will be removed from this study.  You will continue to receive care from your 
BDCP physician regardless of your participation in this study.  In the event medical information 
is recorded for you that may help your physician better treat you, that medical information may 
be given to your doctor.   
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******************************************************************************  
VOLUNTARY CONSENT: All of the above has been explained to me and all of my current 
questions have been answered. I understand that I am encouraged to ask questions about any 
aspect of this research study during the course of the study, and that such future questions will be 
answered by the researchers listed on the first page of this form.   Any questions I have 
concerning my rights as a research participant will be answered by the Human Subjects 
Protection Advocate of the IRB office, University of Pittsburgh (866-212-2668).   
 
By signing this form, I agree to participate in this research study.  A copy of this consent 
form will be given to me.   
 
______________________________ ________________________________________ 
Date      Patient's Signature 
 
 
 ________________________________________ 
 Patient’s Printed Name 
 
CERTIFICATION OF INFORMED CONSENT: I certify that I have explained the nature and 
purpose of this research study to the above-named individual and I have discussed the potential 
benefits and risks of study participation.  Any questions the individual has about this study have 
been answered, and we will always be available to address future questions as they arise. 
 
______________________________ ________________________________________ 
Printed name of Person Obtaining Consent Role in Research Study 
 
 
_____________________________  ________________________________________ 
Signature of Person Obtaining Consent Date 
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APPENDIX F 
EXPLANATION OF TESTING PROCEDURES 
______________________________________________________________________________ 
“You are about to take part in an exercise study investigating the effects of aerobic 
exercise on a blood chemical in clinically diagnosed bipolar subjects.  We will assess your 
height, weight, body circumference measurements and body composition.  We will then ask you 
to rate your current mood on a Likert 7 point scale.  Next, a certified phlebotomist will draw a 
small sample of blood.  You will then be asked to exercise on a treadmill for 30 minutes.  If at 
any time you feel light headed, dizzy, nauseous, or overly fatigued it is important to inform the 
investigator.  If you are having any of these symptoms, you may terminate the test.  Remember, 
you have the ultimate say in stopping the test if you are feeling at all ill during the exam.”   
 
“After the 30-minute exercise bout, a second sample of blood will be drawn.  You will be 
asked to again, rate your mood.  You will be offered water and/or juice and paid your stipend.”  
 
“As with any bout of exercise there is always a risk of abnormal blood pressure, fainting, 
irregular heart rhythm and in rare instances heart attack, as outlined in this informed consent.  
You have read and signed the informed consent and noted that you understand and are aware of 
the outlined risks and will not hold the university or any of its staff responsible for any liability.”  
 
“Do you have any questions before we begin the exam?” 
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APPENDIX G 
LIKERT 7 POINT SCALE FOR GLOBAL WELL-BEING 
ID #: ___________ Date: ___________ Pre-test           Post-test          
 
 
 
Please place a check mark next to the phrase that best describes how you are feeling at this 
moment: 
 
O Severely Depressed 
O Moderately Depressed 
O Mildly Depressed 
O Neutral (not depressed or manic) 
O Mildly Happy 
O Moderately Happy 
O Excessively Happy (manic) 
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APPENDIX H 
DATA COLLECTION FORM 
Data Collection Form 
The effects of an acute bout of aerobic exercise on DHEA levels in bipolar subjects. 
Anne E. Hays 
 
Date__________Time_________ID # _______Room Temp _______Age_______ 
 
Gender:   Male ___Female ___Time of awakening today ____Awake Time (3+hours)_______ 
 
-------------------------------------------------------------------------------------------------------------------- 
Height in Inches  _________ Weight in pounds ________  Resting BP _____/_______ 
--------------------------------------------------------------------------------------------------------------------- 
Waist  _______  Hip _______  Ratio  ________ 
--------------------------------------------------------------------------------------------------------------------- 
 
Time of Blood Draw 1: __________   Hct: _____________________ 
 
--------------------------------------------------------------------------------------------------------------------- 
 
APHRM: __________  70% APHRM ___________ 
 
Heart Rate Range for Test: (70% APRHM+ 5) _____________ 
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Exercise Test 
Minute     Speed    Grade          HR    Minute        Speed        Grade    HR 
0 2.2 0  15-
BP: 
   
1 2.2 0  16    
2    17    
3    18    
4    19    
5 – 
BP: 
   20-
BP: 
   
6    21    
7    22    
8    23    
9    24    
10-
BP: 
   25 
cool down 
   
11    26-
BP: 
   
12    27    
13    28    
14    29-
BP: 
   
 
--------------------------------------------------------------------------------------------------------------------- 
 
Time of Blood Draw 2: __________   Hct: _______________________ 
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APPENDIX I 
HEALTH SUMMARY 
 
Date:  ___________ 
 
Thank you for participating in this research study.  We’d like to help you understand some of the 
health information we learned about you today. 
 
Today your height was measured at: _______________ in or ________ ft, _________ in 
 
 
BODY COMPOSITION 
Your current weight is:___________________lbs 
 
We estimated your body composition to be __________%. 
 
For men, a healthy body fat range is between 10%-22%.  Females are considered healthy in the 
20-32% range.  
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WAIST TO HIP RATIO 
 
Another indicator of health is abdominal adiposity or “apple” and “pear” shaped. Your 
health is affected not only by how much fat you have, but also where that fat is stored.  People 
who gain weight in their hips and buttocks have a lower risk for heart diseases when compared to 
people that store fat primarily in their abdominal region. 
 
If you are an “apple” rather than a “pear” you have a higher risk for health problems such 
as diabetes, coronary heart disease and high blood pressure.  There is nothing you can do to 
change your body type.  That is something that is inherited, however you can take special care to 
keep your weight at a healthy level, eat nutritiously, exercise and maintain other healthy lifestyle 
habits.  
As long as you avoid excess weight, being an “apple” vs. a “pear” doesn’t put you at 
special risk.  Pears need to keep their weight at a healthy level too.   
For men, the optimal value for a waist to hip ratio is below .95.  For women, the ratio 
should be lower than .86. 
Your waist to hip ratio is:________. 
 
 
BLOOD PRESSURE 
 
The American Heart Association has blood pressure guidelines to help you understand 
what your blood pressure reading means.  Under these guidelines, a resting blood pressure 
reading below 120/80 millimeters of mercury (mm Hg) is considered “normal.” If your resting 
blood pressure is consistently 140/90 mm Hg or higher, you have high blood pressure. A reading 
in between these levels places you in the prehypertensive category. Under the new guidelines, a 
reading of 115/75 is the level above which your risk of cardiovascular complications starts to 
increase. 
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 The prehypertensive category sets systolic pressure from 120 to 139 and diastolic 
pressure from 80 to 89 as a warning zone — time to take action against increasing your risk for 
heart disease, stroke and kidney disease. Consult your healthcare professional if you are in the 
prehypertensive range or hypertensive range and start managing your blood pressure now. 
 
Today’s Resting Blood Pressure Reading:  ______/________ 
 
 
HEART RATE RANGE 
Your age predicted maximal heart rate is: ______________ beats per minute.  It is 
recommended that a healthy individual exercise at 55-85% of their maximal heart rate when 
participating in cardiovascular activity.   That means that when you exercise your heart rate 
should be between ________ and ______ beats in a 60 second count, or between ______ and 
______ in a 10 second count. 
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APPENDIX J 
ACSM CRITERIA FOR TERMINATION OF AN EXERCISE TEST 
General Indications for Stopping Exercise Testing in Low-Risk Adults 
ACSM Guidelines for Exercise Testing and Prescription 
 
1. Onset of angina or angina-like symptoms 
2. Drop in systolic blood pressure of >10mm Hg from baseline blood pressure despite an 
increase in work load 
3. Excessive rise in blood pressure: systolic pressure > 250 mm Hg or diastolic pressure 
>115 mm Hg 
4. Shortness of breath, wheezing, leg cramps or claudication 
5. Signs of poor perfusion: light-headedness, confusion, ataxia, pallor, cyanosis, nausea, or 
cold and clammy skin 
6. Failure of heart rate to increase with increased exercise intensity 
7. Noticeable change in heart rhythm 
8. Subject requests to stop 
9. Physical or verbal manifestations of severe fatigue 
10. Failure of the testing equipment 
 
 
 
 
 
 
 
 
 
 
 87 
APPENDIX K 
REPEATED MEASURES ANOVA WITH MAIN EFFECTS FOR EXERCISE AND 
GENDER 
Tests of Within-Subjects Effects 
 
Measure: MEASURE_1  
Source   
Type III Sum 
of Squares df Mean Square F Sig. 
Sphericity Assumed 956.327 1 956.327 7.244 .013
Greenhouse-Geisser 956.327 1.000 956.327 7.244 .013
Huynh-Feldt 956.327 1.000 956.327 7.244 .013
DHEAS 
Lower-bound 956.327 1.000 956.327 7.244 .013
Sphericity Assumed 27.188 1 27.188 .206 .654
Greenhouse-Geisser 27.188 1.000 27.188 .206 .654
Huynh-Feldt 27.188 1.000 27.188 .206 .654
DHEAS * Gender 
Lower-bound 27.188 1.000 27.188 .206 .654
Sphericity Assumed 3168.505 24 132.021   
Greenhouse-Geisser 3168.505 24.000 132.021   
Huynh-Feldt 3168.505 24.000 132.021   
Error(DHEAS) 
Lower-bound 3168.505 24.000 132.021   
 
 
 
Tests of Between-Subjects Effects 
 
Measure: MEASURE_1  
Transformed Variable: Average  
Source 
Type III Sum 
of Squares df Mean Square F Sig. 
Intercept 1915545.849 1 1915545.849 45.086 .000
Gender 186169.422 1 186169.422 4.382 .047
Error 1019676.388 24 42486.516   
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APPENDIX L 
INDIVIDUAL DHEAS RESPONSES TO EXERCISE 
Subject Number DHEAS Pre-exercise (ug/dl)   DHEAS Post-exercise (ug/dl) 
    1.00   185.00   191.00 
    3.00   216.00   213.00 
    7.00   146.00   158.00 
   11.00   122.00   136.00 
   13.00   132.00   123.00 
   15.00   528.00   559.00 
   19.00    47.60    43.70 
   23.00   723.00   749.00 
   25.00   201.00   206.00 
   27.00    74.20    85.40 
   29.00   239.00   254.00 
   33.00   246.00   298.00 
   35.00   348.00   322.00 
    2.00   131.00   124.00 
    4.00   159.00   186.00 
    8.00   134.00   138.00 
   10.00    41.20    46.40 
   16.00   307.00   322.00 
   18.00    74.70    84.00 
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   20.00   132.00   141.00 
   22.00    98.50    92.60 
   30.00   108.00   109.00 
   34.00    53.60    58.00 
   36.00    92.90    91.60 
   38.00   136.00   134.00 
   40.00   203.00   237.00 
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